Common	O
and	O
distinct	O
intracellular	O
signaling	O
pathways	O
in	O
human	B-cell_type
neutrophils	I-cell_type
utilized	O
by	O
platelet	B-protein
activating	I-protein
factor	I-protein
and	O
FMLP	B-protein
.	O

Stimulation	O
of	O
human	B-cell_type
neutrophils	I-cell_type
with	O
chemoattractants	B-protein
FMLP	B-protein
or	O
platelet	B-protein
activating	I-protein
factor	I-protein
(	O
PAF	B-protein
)	O
results	O
in	O
different	O
but	O
overlapping	O
functional	O
responses	O
.	O

We	O
questioned	O
whether	O
these	O
differences	O
might	O
reflect	O
patterns	O
of	O
intracellular	O
signal	O
transduction	O
.	O

Stimulation	O
with	O
either	O
PAF	B-protein
or	O
FMLP	B-protein
resulted	O
in	O
equivalent	O
phosphorylation	O
and	O
activation	O
of	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	I-protein
MAPk	I-protein
)	I-protein
homologue	I-protein
38-kD	B-protein
murine	I-protein
MAP	I-protein
kinase	I-protein
homologous	O
to	O
HOG-1	B-protein
(	I-protein
p38	I-protein
)	I-protein
MAPk	I-protein
.	O

Neither	O
FMLP	B-protein
nor	O
PAF	B-protein
activated	O
c-jun	B-protein
NH2-terminal	I-protein
MAPk	I-protein
(	O
JNKs	B-protein
)	O
.	O

Under	O
identical	O
conditions	O
,	O
FMLP	B-protein
but	O
not	O
PAF	B-protein
,	O
resulted	O
in	O
significant	O
p42/44	B-protein
(	I-protein
ERK	I-protein
)	I-protein
MAPk	I-protein
activation	O
.	O

Both	O
FMLP	B-protein
and	O
PAF	B-protein
activated	I-protein
MAP	I-protein
kinase	I-protein
kinase-3	I-protein
(	O
MKK3	B-protein
)	O
,	O
a	O
known	O
activator	O
of	O
p38	B-protein
MAPk	I-protein
.	O

Both	O
MAP	B-protein
ERK	I-protein
kinase	I-protein
kinase-1	I-protein
(	O
MEKK1	B-protein
)	O
and	O
Raf	B-protein
are	O
activated	O
strongly	O
by	O
FMLP	B-protein
,	O
but	O
minimally	O
by	O
PAF	B-protein
.	O

Pertussis	B-protein
toxin	I-protein
blocked	O
FMLP	B-protein
-induced	O
activation	O
of	O
the	O
p42/44	B-protein
(	I-protein
ERK	I-protein
)	I-protein
MAPk	I-protein
cascade	O
,	O
but	O
not	O
that	O
of	O
p38	B-protein
MAPk	I-protein
.	O

A	O
specific	O
p38	B-protein
MAPk	I-protein
inhibitor	O
(	O
SK	O
&	O
F	O
86002	O
)	O
blocked	O
superoxide	O
anion	O
production	O
in	O
response	O
to	O
FMLP	B-protein
and	O
reduced	O
adhesion	O
and	O
chemotaxis	O
in	O
response	O
to	O
PAF	B-protein
or	O
FMLP	B-protein
.	O

These	O
results	O
demonstrate	O
distinct	O
patterns	O
of	O
intracellular	O
signaling	O
for	O
two	O
chemoattractants	B-protein
and	O
suggest	O
that	O
selective	O
activation	O
of	O
intracellular	O
signaling	O
cascades	O
may	O
underlie	O
different	O
patterns	O
of	O
functional	O
responses	O
.	O

Common	NULL
and	NULL
Distinct	NULL
Intracellular	NULL
Signaling	NULL
Pathways	NULL
in	NULL
Human	NULL
Neutrophils	NULL
Utilized	NULL
by	NULL
Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Jerry	NULL
A.	NULL
Nick	NULL
,	NULL
**	NULL
Natalie	NULL
J.	NULL
Avdi	NULL
,	NULL
*	NULL
Scott	NULL
K.	NULL
Young	NULL
,	NULL
*	NULL
Cindy	NULL
Knall	NULL
,	NULL
$	NULL
!	NULL

Par	NULL
Gerwins	NULL
,	NULL
$	NULL
Gary	NULL
L	NULL
.	NULL

Johnson	NULL
,	NULL
$	NULL
!	NULL
``	NULL

and	NULL
G.	NULL
Scott	NULL
Worthen*	NULL
!	NULL

t	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Basic	NULL
Sciences	NULL
,	NULL
and	NULL
\Program	NULL
in	NULL
Molecular	NULL
Signal	NULL
Transduction	NULL
,	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Medicine	NULL
and	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206	NULL
Abstract	NULL
Stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
chemoattractants	NULL
FMLP	NULL
or	NULL
platelet	NULL
activating	NULL
factor	NULL
(	NULL
PAF	NULL
)	NULL
results	NULL
in	NULL
different	NULL
but	NULL
overlapping	NULL
functional	NULL
responses	NULL
.	NULL

We	NULL
questioned	NULL
whether	NULL
these	NULL
differences	NULL
might	NULL
reflect	NULL
patterns	NULL
of	NULL
intracellular	NULL
signal	NULL
transduction	NULL
.	NULL

Stimulation	NULL
with	NULL
either	NULL
PAF	NULL
or	NULL
FMLP	NULL
resulted	NULL
in	NULL
equivalent	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
homologue	NULL
38-kD	NULL
murine	NULL
MAP	NULL
kinase	NULL
homologous	NULL
to	NULL
HOG-1	NULL
(	NULL
p38	NULL
)	NULL
MAPk	NULL
.	NULL

Neither	NULL
FMLP	NULL
nor	NULL
PAF	NULL
activated	NULL
c-jun	NULL
NH	NULL
,	NULL
-terminal	NULL
MAPk	NULL
(	NULL
JNKs	NULL
)	NULL
.	NULL

Under	NULL
identical	NULL
conditions	NULL
,	NULL
FMLP	NULL
but	NULL
not	NULL
PAF	NULL
,	NULL
resulted	NULL
in	NULL
significant	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
activation	NULL
.	NULL

Both	NULL
FMLP	NULL
and	NULL
PAF	NULL
activated	NULL
MAP	NULL
kinase	NULL
kinase-3	NULL
(	NULL
MKK3	NULL
)	NULL
,	NULL
a	NULL
known	NULL
activator	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

Both	NULL
MAP	NULL
ERK	NULL
kinase	NULL
kinase-1	NULL
(	NULL
MEKK1	NULL
)	NULL
and	NULL
Raf	NULL
are	NULL
activated	NULL
strongly	NULL
by	NULL
FMLP	NULL
,	NULL
but	NULL
minimally	NULL
by	NULL
PAF	NULL
.	NULL

Pertussis	NULL
toxin	NULL
blocked	NULL
FMLP-induced	NULL
activation	NULL
of	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
cas-cade	NULL
,	NULL
but	NULL
not	NULL
that	NULL
of	NULL
p38	NULL
MAPK	NULL
.	NULL

A	NULL
specific	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
(	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
)	NULL
blocked	NULL
superoxide	NULL
anion	NULL
production	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
and	NULL
reduced	NULL
adhesion	NULL
and	NULL
chemotaxis	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
or	NULL
FMLP	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
distinct	NULL
patterns	NULL
of	NULL
intracellular	NULL
signaling	NULL
for	NULL
two	NULL
chemoattractants	NULL
and	NULL
suggest	NULL
that	NULL
selective	NULL
activation	NULL
of	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
may	NULL
underlie	NULL
different	NULL
patterns	NULL
of	NULL
functional	NULL
responses	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1997	NULL
.	NULL

99:975-986	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
MAP	NULL
kinases	NULL
+	NULL
superoxide	NULL
«	NULL
adhesion	NULL
«	NULL
neutrophil	NULL
activation	NULL
«	NULL
pertussis	NULL
toxins	NULL
Introduction	NULL
Stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
chemoattractants	NULL
results	NULL
in	NULL
their	NULL
accumulation	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
and	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
spectrum	NULL
of	NULL
responses	NULL
that	NULL
may	NULL
contribute	NULL
to	NULL
tissue	NULL
injury	NULL
.	NULL

In	NULL
the	NULL
adult	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
(	NULL
ARDS	NULL
)	NULL
massive	NULL
neutrophil	NULL
accumulation	NULL
in	NULL
the	NULL
lung	NULL
is	NULL
associated	NULL
with	NULL
significant	NULL
lung	NULL
injury	NULL
,	NULL
while	NULL
in	NULL
other	NULL
disease	NULL
processes	NULL
neutrophil	NULL
accumulation	NULL
can	NULL
result	NULL
in	NULL
negligible	NULL
tissue	NULL
injury	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
different	NULL
stimuli	NULL
can	NULL
result	NULL
in	NULL
different	NULL
responses	NULL
appears	NULL
to	NULL
offer	NULL
clues	NULL
as	NULL
to	NULL
the	NULL
regulatory	NULL
mechanism	NULL
J	NULL
.	NULL

A.	NULL
Nick	NULL
and	NULL
N.J.	NULL
Avdi	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

Address	NULL
all	NULL
correspondence	NULL
to	NULL
Jerry	NULL
A.	NULL
Nick	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
c/o	NULL
G.	NULL
Scott	NULL
Worthen	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
1400	NULL
Jackson	NULL
Street	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80206	NULL
.	NULL

Phone	NULL
:	NULL
303-398-1171	NULL
;	NULL
FAX	NULL
:	NULL
303-398-1851	NULL
;	NULL
E-mail	NULL
:	NULL
worthens	NULL
@	NULL
njc.org	NULL
Received	NULL
for	NULL
publication	NULL
4	NULL
September	NULL
1996	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
12	NULL
December	NULL
1996	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/97/03/0975/12	NULL
$	NULL
2.00	NULL
Volume	NULL
99	NULL
,	NULL
Number	NULL
5	NULL
,	NULL
March	NULL
1997	NULL
,	NULL
975-986	NULL
by	NULL
which	NULL
neutrophils	NULL
routinely	NULL
function	NULL
;	NULL
in	NULL
host	NULL
defense	NULL
neutrophils	NULL
are	NULL
activated	NULL
without	NULL
significant	NULL
injurious	NULL
effects	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
bacterial	NULL
pneumonia	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
situations	NULL
where	NULL
neutrophil	NULL
accumulation	NULL
contributes	NULL
to	NULL
substantial	NULL
lung	NULL
injury	NULL
.	NULL

Two	NULL
stimuli	NULL
that	NULL
highlight	NULL
potential	NULL
differences	NULL
in	NULL
events	NULL
leading	NULL
to	NULL
neutrophil	NULL
activation	NULL
are	NULL
the	NULL
chemoattractants	NULL
FMLP	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
platelet-activating	NULL
factor	NULL
(	NULL
PAF	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

While	NULL
both	NULL
of	NULL
these	NULL
compounds	NULL
are	NULL
potent	NULL
stimulators	NULL
of	NULL
multiple	NULL
functional	NULL
responses	NULL
in	NULL
human	NULL
neutrophils	NULL
,	NULL
the	NULL
repertoire	NULL
of	NULL
responses	NULL
elicited	NULL
by	NULL
each	NULL
is	NULL
distinctly	NULL
different	NULL
.	NULL

Exposure	NULL
to	NULL
FMLP	NULL
results	NULL
in	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
rapid	NULL
functional	NULL
responses	NULL
including	NULL
actin	NULL
assembly	NULL
,	NULL
adherence	NULL
,	NULL
calcium	NULL
influx	NULL
,	NULL
chemokinesis	NULL
,	NULL
chemotaxis	NULL
,	NULL
superoxide	NULL
production	NULL
and	NULL
granule	NULL
enzyme	NULL
release	NULL
(	NULL
5	NULL
)	NULL
.	NULL

While	NULL
a	NULL
number	NULL
of	NULL
functional	NULL
responses	NULL
induced	NULL
by	NULL
PAF	NULL
stimulation	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
induced	NULL
by	NULL
FMLP	NULL
,	NULL
some	NULL
important	NULL
differences	NULL
have	NULL
been	NULL
noted	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
is	NULL
the	NULL
relative	NULL
inability	NULL
of	NULL
neutrophils	NULL
to	NULL
produce	NULL
superoxide	NULL
anion	NULL
after	NULL
PAF	NULL
stimulation	NULL
.	NULL

At	NULL
high	NULL
concentrations	NULL
PAF	NULL
is	NULL
a	NULL
much	NULL
weaker	NULL
agonist	NULL
for	NULL
release	NULL
of	NULL
superoxide	NULL
anion	NULL
and	NULL
granule	NULL
constituents	NULL
than	NULL
is	NULL
FMLP	NULL
,	NULL
and	NULL
under	NULL
physiologic	NULL
conditions	NULL
PAF-induced	NULL
superoxide	NULL
anion	NULL
release	NULL
is	NULL
minimal	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Superoxide	NULL
production	NULL
has	NULL
long	NULL
been	NULL
recognized	NULL
as	NULL
an	NULL
important	NULL
component	NULL
in	NULL
host	NULL
defense	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
contributor	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
lung	NULL
injury	NULL
in	NULL
certain	NULL
inflammatory	NULL
dis-eases	NULL
.	NULL

Individuals	NULL
whose	NULL
neutrophils	NULL
lack	NULL
the	NULL
ability	NULL
to	NULL
produce	NULL
superoxide	NULL
,	NULL
as	NULL
in	NULL
chronic	NULL
granulomatous	NULL
disease	NULL
(	NULL
CGD	NULL
)	NULL
,	NULL
suffer	NULL
from	NULL
recurrent	NULL
bacterial	NULL
and	NULL
fungal	NULL
infections	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Whereas	NULL
excess	NULL
superoxide	NULL
production	NULL
contributes	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
lung	NULL
injury	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Both	NULL
FMLP	NULL
(	NULL
10	NULL
)	NULL
and	NULL
PAF	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
bind	NULL
to	NULL
the	NULL
neutrophil	NULL
cell	NULL
surface	NULL
via	NULL
members	NULL
of	NULL
the	NULL
seven	NULL
trans-membrane	NULL
spanning	NULL
G-protein	NULL
linked	NULL
receptor	NULL
family	NULL
.	NULL

After	NULL
receptor	NULL
activa-tion	NULL
,	NULL
specificity	NULL
of	NULL
the	NULL
functional	NULL
response	NULL
might	NULL
occur	NULL
through	NULL
activation	NULL
of	NULL
distinct	NULL
and	NULL
separate	NULL
effector	NULL
pathways	NULL
(	NULL
as	NULL
shown	NULL
in	NULL
yeast	NULL
)	NULL
,	NULL
or	NULL
through	NULL
combinatorial	NULL
mechanisms	NULL
.	NULL

We	NULL
have	NULL
begun	NULL
to	NULL
address	NULL
the	NULL
central	NULL
hypothesis	NULL
that	NULL
specific	NULL
functional	NULL
responses	NULL
in	NULL
neutrophils	NULL
are	NULL
regulated	NULL
through	NULL
the	NULL
preferential	NULL
utilization	NULL
of	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
resulting	NULL
from	NULL
the	NULL
binding	NULL
of	NULL
stimuli	NULL
to	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

Recent	NULL
studies	NULL
1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
ATF-2	NULL
,	NULL
activated	NULL
transcription	NULL
factor-2	NULL
;	NULL
EGFR	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
;	NULL
ERK	NULL
,	NULL
extracellu-lar	NULL
signal-regulated	NULL
kinases	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
NH	NULL
;	NULL
-terminal	NULL
kinase	NULL
;	NULL
KRPD	NULL
,	NULL
Krebs	NULL
ringer	NULL
phosphate	NULL
buffer	NULL
with	NULL
dextrose	NULL
;	NULL
MAPk	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
Recombinant	NULL
kinase-inactive	NULL
MAPk	NULL
;	NULL
MAPk	NULL
,	NULL
,	NULL
,	NULL
Recombinant	NULL
wild-type	NULL
MAPk	NULL
;	NULL
MEK	NULL
,	NULL
MAP/ERK	NULL
kinase	NULL
(	NULL
also	NULL
termed	NULL
MAP	NULL
kinase	NULL
kinase	NULL
)	NULL
;	NULL
MEK	NULL
recombinant	NULL
kinase-inactive	NULL
MEK1	NULL
;	NULL
MKK3	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
3	NULL
;	NULL
MKK4	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
4	NULL
(	NULL
JNKK	NULL
)	NULL
;	NULL
MEKK	NULL
,	NULL
MEK	NULL
kinase	NULL
(	NULL
MAPk	NULL
kinase	NULL
kinase	NULL
)	NULL
;	NULL
p38	NULL
,	NULL
38-kD	NULL
murine	NULL
MAP	NULL
kinase	NULL
homologous	NULL
to	NULL
HOG-1	NULL
MAPk	NULL
(	NULL
yeast	NULL
)	NULL
;	NULL
PAF	NULL
,	NULL
platelet	NULL
activating	NULL
factor	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
;	NULL
PTX	NULL
,	NULL
pertussis	NULL
toxin	NULL
.	NULL

Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
975	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
FMLP	NULL
to	NULL
a	NULL
seven	NULL
transmembrane	NULL
spanning	NULL
receptor	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
human	NULL
neutrophils	NULL
initiates	NULL
a	NULL
sequence	NULL
of	NULL
protein	NULL
phosphorylation	NULL
events	NULL
including	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Ras-dependent	NULL
kinases	NULL
[	NULL
Raf	NULL
and	NULL
MAP/ERK	NULL
kinase	NULL
kinase-1	NULL
(	NULL
MEKK-1	NULL
)	NULL
]	NULL
(	NULL
13	NULL
)	NULL
which	NULL
then	NULL
phosphorylate	NULL
and	NULL
activate	NULL
the	NULL
MAP/ERK	NULL
kinases	NULL
(	NULL
MEK-1	NULL
and	NULL
MEK-2	NULL
)	NULL
which	NULL
in	NULL
turn	NULL
activate	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
mitogen	NULL
activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPk	NULL
)	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
kinases	NULL
in	NULL
this	NULL
pathway	NULL
is	NULL
maximal	NULL
within	NULL
1-2	NULL
min	NULL
after	NULL
exposure	NULL
to	NULL
FMLP	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathway	NULL
utilized	NULL
by	NULL
the	NULL
human	NULL
neutrophil	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
stimulation	NULL
.	NULL

PAF	NULL
binding	NULL
to	NULL
its	NULL
seven	NULL
trans-membrane	NULL
spanning	NULL
G-protein	NULL
linked	NULL
receptor	NULL
stimulate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
intracellular	NULL
proteins	NULL
(	NULL
17	NULL
)	NULL
,	NULL
these	NULL
intracellular	NULL
signaling	NULL
events	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
include	NULL
significant	NULL
activation	NULL
of	NULL
either	NULL
MEK-1	NULL
(	NULL
18	NULL
)	NULL
or	NULL
MEK-2	NULL
(	NULL
19	NULL
)	NULL
.	NULL

If	NULL
heterogeneity	NULL
of	NULL
neutrophil	NULL
responses	NULL
is	NULL
reflected	NULL
in	NULL
selective	NULL
utilization	NULL
of	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
,	NULL
these	NULL
differences	NULL
might	NULL
ultimately	NULL
result	NULL
in	NULL
distinct	NULL
patterns	NULL
of	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
,	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
families	NULL
of	NULL
MAP	NULL
kinase	NULL
exist	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Known	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
include	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
MAPk	NULL
(	NULL
JNKs	NULL
)	NULL
,	NULL
and	NULL
the	NULL
38-kD	NULL
murine	NULL
MAP	NULL
kinase	NULL
homologous	NULL
to	NULL
HOG-1	NULL
(	NULL
p38	NULL
)	NULL
MAPk	NULL
(	NULL
named	NULL
based	NULL
on	NULL
its	NULL
molecular	NULL
weight	NULL
in	NULL
murine	NULL
cells	NULL
)	NULL
both	NULL
of	NULL
which	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
various	NULL
``	NULL
stress	NULL
``	NULL
stimuli	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
FMLP	NULL
strongly	NULL
activates	NULL
both	NULL
p38	NULL
MAPk	NULL
and	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
,	NULL
while	NULL
PAF	NULL
preferentially	NULL
activates	NULL
p38	NULL
MAPk	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
by	NULL
FMLP	NULL
occurs	NULL
through	NULL
activation	NULL
of	NULL
MEK1/MEK2	NULL
,	NULL
while	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
FMLP	NULL
and	NULL
PAF	NULL
appears	NULL
to	NULL
occur	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
kinase	NULL
3	NULL
(	NULL
MKK3	NULL
)	NULL
.	NULL

Specific	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
a	NULL
bicyclic	NULL
imidazole	NULL
(	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
)	NULL
results	NULL
in	NULL
selective	NULL
loss	NULL
of	NULL
functional	NULL
responses	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
allow	NULL
for	NULL
the	NULL
most	NULL
complete	NULL
analysis	NULL
to	NULL
date	NULL
of	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
used	NULL
by	NULL
two	NULL
distinct	NULL
chemoattractants	NULL
via	NULL
seven-transmembrane	NULL
spanning	NULL
receptors	NULL
,	NULL
corresponding	NULL
to	NULL
different	NULL
functional	NULL
responses	NULL
.	NULL

Methods	NULL
Materials	NULL
.	NULL

Endotoxin	NULL
free	NULL
reagents	NULL
and	NULL
plastics	NULL
were	NULL
used	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Neutrophils	NULL
were	NULL
resuspended	NULL
in	NULL
Krebs	NULL
ringer	NULL
phosphate	NULL
buffer	NULL
(	NULL
KRPD	NULL
)	NULL
pH	NULL
7.2	NULL
with	NULL
0.2	NULL
%	NULL
dextrose	NULL
.	NULL

Salts	NULL
used	NULL
in	NULL
the	NULL
buffer	NULL
were	NULL
purchased	NULL
from	NULL
Mallinckrodt	NULL
Specialty	NULL
Chemicals	NULL
(	NULL
Paris	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

KRPD	NULL
components	NULL
were	NULL
diluted	NULL
in	NULL
endotoxin	NULL
free	NULL
saline	NULL
(	NULL
0.9	NULL
%	NULL
saline	NULL
for	NULL
irrigation	NULL
;	NULL
Abbott	NULL
Laboratories	NULL
)	NULL
and	NULL
prepared	NULL
,	NULL
fresh	NULL
daily	NULL
.	NULL

Phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
cytochalasin	NULL
B	NULL
,	NULL
aprotinin	NULL
,	NULL
leupep-tin	NULL
,	NULL
PMSF	NULL
,	NULL
FMLP	NULL
,	NULL
Bovine	NULL
serum	NULL
albumin	NULL
fraction	NULL
V	NULL
,	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

IP-20	NULL
(	NULL
TTYADFIASGRTGRRNAIHD	NULL
)	NULL
and	NULL
a	NULL
(	NULL
RRELVEPLTPSGEAPNQALLR	NULL
)	NULL
peptides	NULL
were	NULL
synthesized	NULL
by	NULL
Macromolecular	NULL
Resources	NULL
(	NULL
Fort	NULL
Collins	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

PAF	NULL
was	NULL
purchased	NULL
from	NULL
Avanti	NULL
Polar	NULL
Lipids	NULL
,	NULL
Inc.	NULL
(	NULL
Alabaster	NULL
,	NULL
AL	NULL
)	NULL
and	NULL
fura-2	NULL
from	NULL
Molecular	NULL
Probes	NULL
(	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

SK	NULL
&	NULL
F	NULL
86002-A2	NULL
[	NULL
6-	NULL
(	NULL
4-Fluorophenyl	NULL
)	NULL
-2,3-dihydro-5-	NULL
(	NULL
4-pyridinyl	NULL
)	NULL
imidazo	NULL
(	NULL
2,1-b	NULL
)	NULL
thiazole	NULL
dihydrochloride	NULL
]	NULL
was	NULL
provided	NULL
by	NULL
SmithKline	NULL
Beecham	NULL
Pharmaceuticals	NULL
(	NULL
King	NULL
of	NULL
Prussia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

A	NULL
polyclonal	NULL
anti-p38	NULL
antiserum	NULL
was	NULL
raised	NULL
by	NULL
conjugating	NULL
a	NULL
14-amino	NULL
acid	NULL
peptide	NULL
CFVPPPLDQEEMES	NULL
corresponding	NULL
to	NULL
the	NULL
COOH	NULL
of	NULL
HOG-1/p38	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
(	NULL
KLH	NULL
)	NULL
and	NULL
used	NULL
to	NULL
immunize	NULL
rabbits	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
antibody	NULL
was	NULL
defined	NULL
by	NULL
immunoblotting	NULL
of	NULL
recombinant	NULL
p38	NULL
and	NULL
cell	NULL
lysates	NULL
.	NULL

Anti-phosphotyrosine	NULL
and	NULL
anti-MKK3	NULL
were	NULL
obtained	NULL
976	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

from	NULL
Upstate	NULL
Biotechnology	NULL
Incorporated	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-p38	NULL
MAPk	NULL
,	NULL
anti-c-Raf-1	NULL
,	NULL
anti-B-Raf	NULL
,	NULL
anti-ERK1	NULL
(	NULL
p44	NULL
MAPk	NULL
)	NULL
,	NULL
and	NULL
anti-ERK2	NULL
(	NULL
p42	NULL
MAPk	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-MEKK-1	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
recombinant	NULL
fragment	NULL
of	NULL
MEKK-1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Expression	NULL
and	NULL
purification	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

GST	NULL
-c-Junj	NULL
»	NULL
and	NULL
activated	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
;	NULL
_	NULL
;	NULL
,	NULL
were	NULL
prepared	NULL
using	NULL
methods	NULL
previously	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Kinase	NULL
inactive	NULL
MEK	NULL
1	NULL
(	NULL
MEK	NULL
1	NULL
}	NULL
,	NULL
,	NULL
)	NULL
and	NULL
wild	NULL
type	NULL
MEK1	NULL
(	NULL
MEK1	NULL
,	NULL
,	NULL
,	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
and	NULL
p38	NULL
MAPk	NULL
,	NULL
,	NULL
,	NULL
were	NULL
expressed	NULL
utilizing	NULL
a	NULL
construct	NULL
designed	NULL
with	NULL
a	NULL
polyhistidine	NULL
sequence	NULL
at	NULL
the	NULL
prepared	NULL
by	NULL
ligating	NULL
NspB11-digested	NULL
HL60	NULL
cell	NULL
p38	NULL
MAPk	NULL
cDNA	NULL
with	NULL
Pvull-digested	NULL
bacterial	NULL
expression	NULL
vector	NULL
pRSETC	NULL
.	NULL

A	NULL
kinase-inactive	NULL
p38	NULL
MAPk	NULL
fusion	NULL
protein	NULL
was	NULL
created	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
in	NULL
which	NULL
the	NULL
active	NULL
site	NULL
lysine-53	NULL
is	NULL
converted	NULL
to	NULL
methionine	NULL
using	NULL
the	NULL
oligonucleotide	NULL
5-TGCATAT-CAT*GAAAATCAG-3	NULL
'	NULL
.	NULL

After	NULL
expression	NULL
by	NULL
E.	NULL
coli	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
recombinant	NULL
p38	NULL
MAPk	NULL
was	NULL
confirmed	NULL
by	NULL
resequencing	NULL
.	NULL

Neutrophil	NULL
function	NULL
assays	NULL
.	NULL

Neutrophil	NULL
adherence	NULL
after	NULL
stimulation	NULL
with	NULL
PAF	NULL
or	NULL
FMLP	NULL
was	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Actin	NULL
assembly	NULL
was	NULL
determined	NULL
in	NULL
triplicate	NULL
by	NULL
NBD-phallacidin	NULL
staining	NULL
and	NULL
analyzed	NULL
by	NULL
a	NULL
Coulter	NULL
EPICs	NULL
C	NULL
cytofluorograph	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
superoxide	NULL
anion	NULL
was	NULL
determined	NULL
in	NULL
triplicate	NULL
experiments	NULL
using	NULL
methods	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Neutrophils	NULL
were	NULL
pretreated	NULL
with	NULL
cytochalasin	NULL
B	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
for	NULL
5	NULL
min	NULL
before	NULL
stimulation	NULL
in	NULL
all	NULL
superoxide	NULL
anion	NULL
release	NULL
assays	NULL
.	NULL

Neutrophil	NULL
migration	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
standard	NULL
micropore	NULL
filter	NULL
assay	NULL
using	NULL
blind	NULL
well	NULL
Boyden	NULL
chambers	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
lower	NULL
well	NULL
of	NULL
the	NULL
chamber	NULL
was	NULL
filled	NULL
with	NULL
KRPD-HSA	NULL
with	NULL
or	NULL
without	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
well	NULL
was	NULL
then	NULL
overlaid	NULL
with	NULL
an	NULL
8	NULL
M	NULL
pore	NULL
size	NULL
,	NULL
150-uM	NULL
thick	NULL
nitrocellulose	NULL
filter	NULL
(	NULL
Sartorius	NULL
)	NULL
prewetted	NULL
in	NULL
KRPD-HSA	NULL
.	NULL

The	NULL
upper	NULL
well	NULL
was	NULL
screwed	NULL
down	NULL
onto	NULL
the	NULL
filter	NULL
and	NULL
10°	NULL
neutrophils	NULL
in	NULL
200	NULL
pl	NULL
were	NULL
added	NULL
to	NULL
the	NULL
upper	NULL
well	NULL
.	NULL

The	NULL
chambers	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
a	NULL
humidified	NULL
,	NULL
CO	NULL
,	NULL
incubator	NULL
at	NULL
37°C	NULL
for	NULL
1-2	NULL
h.	NULL
After	NULL
incuba-tion	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
harvested	NULL
and	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
hematoxylin	NULL
,	NULL
dehydrated	NULL
,	NULL
cleared	NULL
and	NULL
mounted	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
tested	NULL
in	NULL
triplicate	NULL
with	NULL
three	NULL
independent	NULL
cell	NULL
counts	NULL
per	NULL
replicate	NULL
filter	NULL
at	NULL
400	NULL
%	NULL
and	NULL
at	NULL
a	NULL
specific	NULL
depth	NULL
of	NULL
field	NULL
from	NULL
the	NULL
top	NULL
of	NULL
the	NULL
filter	NULL
for	NULL
a	NULL
total	NULL
of	NULL
nine	NULL
readings	NULL
per	NULL
sample	NULL
.	NULL

Mobilization	NULL
of	NULL
intracellular	NULL
calcium	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
was	NULL
analyzed	NULL
by	NULL
incubation	NULL
of	NULL
neutrophils	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
with	NULL
fura-2	NULL
(	NULL
1.5	NULL
M	NULL
,	NULL
final	NULL
concentra-tion	NULL
)	NULL
(	NULL
31	NULL
)	NULL
for	NULL
45	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
50	NULL
ml	NULL
KRPD	NULL
and	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
%	NULL
/ml	NULL
in	NULL
KRPB	NULL
containing	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Fluorescence	NULL
of	NULL
the	NULL
neutrophil	NULL
population	NULL
after	NULL
stimulation	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
was	NULL
then	NULL
determined	NULL
by	NULL
dual	NULL
ex-citation-emission	NULL
spectofluorimeter	NULL
using	NULL
excitation	NULL
wavelengths	NULL
of	NULL
340	NULL
and	NULL
380	NULL
nm	NULL
with	NULL
an	NULL
emission	NULL
wavelength	NULL
of	NULL
510	NULL
nm	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
fluorescence	NULL
intensity	NULL
at	NULL
340	NULL
and	NULL
380	NULL
nm	NULL
is	NULL
proportional	NULL
to	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
,	NULL
The	NULL
maximum	NULL
[	NULL
Ca**	NULL
]	NULL
;	NULL
measured	NULL
after	NULL
stimulation	NULL
of	NULL
cells	NULL
pretreated	NULL
with	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
the	NULL
maximum	NULL
after	NULL
stimulation	NULL
of	NULL
cells	NULL
not	NULL
exposed	NULL
to	NULL
SK	NULL
&	NULL
F	NULL
86002.	NULL
p38	NULL
MAPk	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
neutrophils	NULL
isolated	NULL
by	NULL
the	NULL
plasma	NULL
percoll	NULL
method	NULL
(	NULL
32	NULL
)	NULL
were	NULL
stimulated	NULL
and	NULL
lysed	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
achieved	NULL
using	NULL
p38	NULL
MAPk	NULL
antisera	NULL
.	NULL

Beads	NULL
were	NULL
resuspended	NULL
in	NULL
25	NULL
pl	NULL
kinase	NULL
mix	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
200	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
uM	NULL
ATP	NULL
,	NULL
20	NULL
Ci	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
,	NULL
2	NULL
mM	NULL
dTT	NULL
,	NULL
100	NULL
M	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
25	NULL
mM	NULL
B-glyc-erolphosphate	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
a	NULL
recombinant	NULL
fragment	NULL
of	NULL
activated	NULL
transcription	NULL
factor	NULL
2	NULL
(	NULL
ATF-2	NULL
,	NULL
;	NULL
;	NULL
,	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
with	NULL
2	NULL
%	NULL
Laemmli	NULL
buffer	NULL
and	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
with	NULL
quantification	NULL
of	NULL
activity	NULL
by	NULL
autoradiography	NULL
and	NULL
phosphorimaging	NULL
,	NULL
and	NULL
qualitative	NULL
analysis	NULL
of	NULL
enzyme	NULL
presence	NULL
and	NULL
phosphorylation	NULL
by	NULL
immunoblotting	NULL
.	NULL

JNK	NULL
,	NULL
Raf	NULL
,	NULL
and	NULL
MKK3	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
.	NULL

JNK	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
(	NULL
25	NULL
)	NULL
and	NULL
anti	NULL
c-Raf-1	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
,	NULL
33	NULL
)	NULL
.	NULL

MKK3	NULL
:	NULL
Neutrophils	NULL
,	NULL
stimulated	NULL
with	NULL
either	NULL
10-8	NULL
M	NULL
FMLP	NULL
or	NULL
10-8	NULL
M	NULL
PAF	NULL
for	NULL
90	NULL
s	NULL
were	NULL
lysed	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
as	NULL
described	NULL
for	NULL
MEK1/MEK2	NULL
(	NULL
25	NULL
)	NULL
with	NULL
minor	NULL
modifica-tions	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-MKK3	NULL
antibody	NULL
and	NULL
p38	NULL
was	NULL
used	NULL
as	NULL
substrate	NULL
for	NULL
the	NULL
kinase	NULL
assay	NULL
.	NULL

Anion	NULL
exchange	NULL
separation	NULL
of	NULL
MAP	NULL
kinases	NULL
.	NULL

The	NULL
identity	NULL
and	NULL
activity	NULL
of	NULL
MAPk	NULL
family	NULL
members	NULL
was	NULL
determined	NULL
by	NULL
Mono-Q/ion-exchange	NULL
chromatography	NULL
(	NULL
at	NULL
4°C	NULL
with	NULL
a	NULL
BioLogic	NULL
FPLC	NULL
System	NULL
)	NULL
of	NULL
neutrophil	NULL
lysates	NULL
followed	NULL
by	NULL
assessment	NULL
of	NULL
kinase	NULL
activity	NULL
and	NULL
immunoblotting	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

P42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
immunoprecipitation	NULL
,	NULL
kinase	NULL
assay	NULL
,	NULL
and	NULL
identification	NULL
.	NULL

Neutrophils	NULL
resuspended	NULL
at	NULL
20	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
were	NULL
incubated	NULL
in	NULL
complete	NULL
KRPD	NULL
for	NULL
30	NULL
min	NULL
and	NULL
stimulated	NULL
with	NULL
either	NULL
FMLP	NULL
or	NULL
PAF	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
and	NULL
the	NULL
triton-soluble	NULL
lysates	NULL
,	NULL
precleared	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-p42/	NULL
44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
beads	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
RIPA	NULL
buffer	NULL
,	NULL
twice	NULL
in	NULL
PAN	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
50	NULL
pl	NULL
reaction	NULL
mix	NULL
(	NULL
containing	NULL
50	NULL
mM	NULL
B-gly-cerophosphate	NULL
[	NULL
pH	NULL
7.2	NULL
]	NULL
,	NULL
100	NULL
wM	NULL
Na	NULL
;	NULL
VO4	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
200	NULL
uM	NULL
ATP	NULL
,	NULL
50	NULL
g/ml	NULL
IP20	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
400	NULL
pM	NULL
4	NULL
&	NULL
,	NULL
peptide	NULL
,	NULL
and	NULL
2	NULL
Ci	NULL
[	NULL
y-P	NULL
]	NULL
-ATP	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
with	NULL
a	NULL
10-s	NULL
centrifugation	NULL
at	NULL
5,000	NULL
rpm	NULL
and	NULL
the	NULL
bead	NULL
supernatant	NULL
was	NULL
treated	NULL
in	NULL
two	NULL
ways	NULL
:	NULL
(	NULL
a	NULL
)	NULL
25	NULL
pl	NULL
supernatant	NULL
was	NULL
added	NULL
to	NULL
tubes	NULL
containing	NULL
25	NULL
pl	NULL
25	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
TCA	NULL
solution	NULL
and	NULL
45	NULL
pl	NULL
from	NULL
mixture	NULL
was	NULL
spotted	NULL
on	NULL
P81	NULL
filter	NULL
discs	NULL
.	NULL

These	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
75	NULL
mM	NULL
phosphoric	NULL
acid	NULL
and	NULL
once	NULL
in	NULL
acetone	NULL
before	NULL
being	NULL
dried	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
B-counter	NULL
;	NULL
(	NULL
b	NULL
)	NULL
25	NULL
pl	NULL
of	NULL
2X	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
containing	NULL
40	NULL
mM	NULL
DTT	NULL
was	NULL
added	NULL
to	NULL
the	NULL
tubes	NULL
containing	NULL
the	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
and	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
supernatant	NULL
.	NULL

Samples	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
at	NULL
100°C	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
ni	NULL
trocellulose	NULL
and	NULL
then	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
and	NULL
then	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
antibodies	NULL
.	NULL

Inhibitor	NULL
studies	NULL
.	NULL

Inhibition	NULL
of	NULL
Gi-proteins	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
of	NULL
neutrophils	NULL
in	NULL
KRPD	NULL
containing	NULL
500	NULL
ng/ml	NULL
pertussis	NULL
toxin	NULL
(	NULL
List	NULL
Biologicals	NULL
,	NULL
Campbell	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
stimulation	NULL
.	NULL

In	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
of	NULL
neutrophils	NULL
in	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

In	NULL
vitro	NULL
inhibition	NULL
of	NULL
MAPks	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
to	NULL
immunoprecipitated	NULL
p38	NULL
MAPk	NULL
or	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
followed	NULL
immediately	NULL
by	NULL
the	NULL
kinase	NULL
assays	NULL
described	NULL
above	NULL
.	NULL

Results	NULL
Partial	NULL
purification	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
and	NULL
p38	NULL
MAPK	NULL
by	NULL
anion-exchange	NULL
chromatography	NULL
.	NULL

To	NULL
evaluate	NULL
simultaneously	NULL
the	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
distinct	NULL
from	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
,	NULL
human	NULL
neutrophils	NULL
were	NULL
stimulated	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
for	NULL
90	NULL
s	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
the	NULL
proteins	NULL
in	NULL
each	NULL
cell	NULL
lysate	NULL
were	NULL
separated	NULL
by	NULL
anion	NULL
exchange	NULL
chromatography	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
demonstrates	NULL
that	NULL
exposure	NULL
of	NULL
human	NULL
neutrophils	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
kinase	NULL
to	NULL
phosphorylate	NULL
ATF	NULL
2	NULL
;	NULL
j	NULL
;	NULL
,	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Lysates	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
D	NULL
)	NULL
demonstrated	NULL
equivalent	NULL
amounts	NULL
of	NULL
kinase	NULL
activity	NULL
eluting	NULL
in	NULL
fractions	NULL
29-31	NULL
.	NULL

As	NULL
phosphorylation	NULL
of	NULL
a	NULL
specific	NULL
tyrosine	NULL
(	NULL
and	NULL
threonine	NULL
)	NULL
residue	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
all	NULL
known	NULL
MAPks	NULL
,	NULL
proteins	NULL
from	NULL
each	NULL
fraction	NULL
were	NULL
electrophoretically	NULL
FMLP	NULL
o	NULL
Pr	NULL
d	NULL
3	NULL
&	NULL
Go	NULL
Figure	NULL
1	NULL
.	NULL

Anion	NULL
exchange	NULL
chromatography	NULL
elution	NULL
profile	NULL
of	NULL
lysates	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
10~	NULL
%	NULL
M	NULL
)	NULL
for	NULL
90	NULL
s	NULL
identifying	NULL
the	NULL
phosphorylation	NULL
and	NULL
ac-p	NULL
_	NULL
tivation	NULL
of	NULL
the	NULL
p38	NULL
MAPk	NULL
.	NULL

(	NULL
A4	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAPK	NULL
isolated	NULL
from	NULL
FMLP-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
de-	NULL
«	NULL
-	NULL
dt	NULL
~	NULL
PAF	NULL
ation	NULL
of	NULL
ATF-2	NULL
(	NULL
anti-PY	NULL
F	NULL
ant-p38	NULL
a	NULL
»	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
70	NULL
8	NULL
9	NULL
10	NULL
I1	NULL
12	NULL
13	NULL
14	NULL
IS	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
2	NULL
%	NULL
29	NULL
30	NULL
31	NULL
32	NULL
3	NULL
%	NULL
A4	NULL
AS	NULL
is	NULL
Fraction	NULL
Number	NULL
termined	NULL
by	NULL
incorporation	NULL
of	NULL
*P	NULL
into	NULL
a	NULL
p38	NULL
MAPk	NULL
substrate	NULL
(	NULL
re-combinant	NULL
ATF-2-1	NULL
,	NULL
,	NULL
)	NULL
.	NULL

Peak	NULL
enzymatic	NULL
activity	NULL
eluted	NULL
in	NULL
fractions	NULL
29-31	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
FMLP-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
A	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Proteins	NULL
containing	NULL
a	NULL
phosphorylated	NULL
tyrosine	NULL
residue	NULL
were	NULL
present	NULL
in	NULL
fraction	NULL
29-31	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
peak	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Elution	NULL
of	NULL
p38	NULL
MAPk	NULL
from	NULL
FMLP-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
B	NULL
were	NULL
restained	NULL
with	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localization	NULL
of	NULL
p38	NULL
MAPk	NULL
to	NULL
fractions	NULL
29-31	NULL
.	NULL

A	NULL
small	NULL
amount	NULL
of	NULL
unphosphorylated	NULL
and	NULL
inactive	NULL
p38	NULL
MAPk	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
in	NULL
fraction	NULL
11	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAPk	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
as	NULL
in	NULL
A	NULL
.	NULL

Peak	NULL
enzymatic	NULL
activity	NULL
eluted	NULL
in	NULL
fractions	NULL
29-31	NULL
,	NULL
and	NULL
is	NULL
equivalent	NULL
in	NULL
magnitude	NULL
to	NULL
the	NULL
activity	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
FMLP	NULL
.	NULL

(	NULL
£	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
D	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Proteins	NULL
containing	NULL
a	NULL
phosphorylated	NULL
tyrosine	NULL
residue	NULL
were	NULL
present	NULL
in	NULL
fraction	NULL
29-31	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
peak	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Elution	NULL
of	NULL
p38	NULL
MAPk	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
£	NULL
were	NULL
restained	NULL
with	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localiza-	NULL
tion	NULL
of	NULL
p38	NULL
MAPk	NULL
to	NULL
fractions	NULL
29-31	NULL
.	NULL

As	NULL
with	NULL
FMLP-stimulated	NULL
cells	NULL
,	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
unphosphorylated	NULL
and	NULL
inactive	NULL
p38	NULL
MAPk	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
in	NULL
fraction	NULL
11	NULL
.	NULL

Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
977	NULL
Figure	NULL
2	NULL
.	NULL

Anion	NULL
exchange	NULL
chromatography	NULL
elution	NULL
profile	NULL
of	NULL
lysates	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
for	NULL
90	NULL
s	NULL
identifying	NULL
the	NULL
phosphorylation	NULL
and	NULL
ac	NULL
tivation	NULL
of	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
®	NULL
MAP	NULL
kinases	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinases	NULL
from	NULL
FMLP-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
P	NULL
into	NULL
Peak	NULL
enzymatic	NULL
activity	NULL
eluted	NULL
in	NULL
fractions	NULL
20-22	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
m	NULL
A	NULL
E	NULL
FMLP	NULL
-a	NULL
P	NULL
©	NULL
E	NULL
£	NULL
6	NULL
&	NULL
.5	NULL
3	NULL
%	NULL
$	NULL
=	NULL
&	NULL
.	NULL

$	NULL
&	NULL
U	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
L	NULL
T	NULL
I	NULL
I	NULL
1	NULL
«	NULL
-	NULL
&	NULL
«	NULL
B	NULL
anti-PY	NULL
C	NULL
_	NULL
anti-MAPK	NULL
D	NULL
&	NULL
§	NULL
_	NULL
|	NULL
rar	NULL
C	NULL
E	NULL
s	NULL
&	NULL
Fig	NULL
£	NULL
%	NULL
|	NULL
if	NULL
£5	NULL
i	NULL
_	NULL
eso	NULL
Sea	NULL
*	NULL
*	NULL
~8-0-0-90-9-4	NULL
``	NULL
P	NULL
I	NULL
T	NULL
1	NULL
I	NULL
I	NULL
I	NULL
U	NULL
I	NULL
I	NULL
I	NULL
T	NULL
u	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
I	NULL
I	NULL
T	NULL
u	NULL
U	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
©	NULL
tag	NULL
,	NULL
he	NULL
wa	NULL
aa	NULL
E	NULL
anti-PY	NULL
g-	NULL
4	NULL
F	NULL
_	NULL
anti-	NULL
MAPK	NULL
Fraction	NULL
Number	NULL
=	NULL
2	NULL
3	NULL
4	NULL
S	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1S	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
3	NULL
%	NULL
34	NULL
35	NULL
36	NULL
FMLP	NULL
-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
A	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Proteins	NULL
containing	NULL
a	NULL
phosphorylated	NULL
ty	NULL
rosine	NULL
residue	NULL
were	NULL
present	NULL
in	NULL
fraction	NULL
20-22	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
peak	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activity	NULL
,	NULL
as	NULL
well	NULL
as	NULL
fractions	NULL
29-31	NULL
(	NULL
p38	NULL
MAPK	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Elution	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
from	NULL
FMLP-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
B	NULL
were	NULL
restained	NULL
with	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localization	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
to	NULL
fractions	NULL
18-22	NULL
.	NULL

The	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
eluting	NULL
in	NULL
fractions	NULL
18-19	NULL
was	NULL
not	NULL
phosphorylated	NULL
or	NULL
activated	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
as	NULL
in	NULL
A	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
D	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Although	NULL
some	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
fractions	NULL
18-22	NULL
which	NULL
contain	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
,	NULL
the	NULL
immunoprobing	NULL
of	NULL
fractions	NULL
20-22	NULL
was	NULL
distinctly	NULL
different	NULL
then	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Proteins	NULL
containing	NULL
a	NULL
phosphorylated	NULL
tyrosine	NULL
residue	NULL
were	NULL
also	NULL
present	NULL
in	NULL
fraction	NULL
29-31	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
elution	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Elution	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
E	NULL
were	NULL
restained	NULL
with	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localization	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
to	NULL
fractions	NULL
18-22	NULL
,	NULL
in	NULL
similar	NULL
quantities	NULL
to	NULL
the	NULL
cell	NULL
lysate	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
C	NULL
)	NULL
.	NULL

separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B	NULL
and	NULL
E	NULL
)	NULL
demonstrating	NULL
equivalent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
after	NULL
stimulation	NULL
with	NULL
either	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
restained	NULL
with	NULL
an	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
C	NULL
and	NULL
F	NULL
)	NULL
to	NULL
independently	NULL
confirm	NULL
the	NULL
location	NULL
of	NULL
the	NULL
p38	NULL
MAPk	NULL
.	NULL

Immunoblotting	NULL
revealed	NULL
p38	NULL
MAPk	NULL
eluting	NULL
at	NULL
two	NULL
locations	NULL
of	NULL
the	NULL
gradient	NULL
:	NULL
a	NULL
small	NULL
peak	NULL
eluted	NULL
at	NULL
fraction	NULL
11	NULL
,	NULL
and	NULL
an	NULL
apparently	NULL
larger	NULL
peak	NULL
at	NULL
fractions	NULL
29-31	NULL
that	NULL
corresponded	NULL
to	NULL
the	NULL
enzymatic	NULL
activity	NULL
.	NULL

An	NULL
aliquot	NULL
from	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
was	NULL
removed	NULL
to	NULL
determine	NULL
for	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activity	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
demonstrates	NULL
that	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
,	NULL
but	NULL
not	NULL
PAF	NULL
,	NULL
results	NULL
in	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
p42/p44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
sample	NULL
from	NULL
each	NULL
fraction	NULL
to	NULL
phosphorylate	NULL
EGFRe	NULL
,	NULL
,	NULL
_45	NULL
;	NULL
.	NULL

Cell	NULL
lysates	NULL
of	NULL
human	NULL
neutrophils	NULL
exposed	NULL
to	NULL
FMLP	NULL
for	NULL
90	NULL
s	NULL
demonstrated	NULL
a	NULL
robust	NULL
peak	NULL
of	NULL
activity	NULL
in	NULL
fractions	NULL
20-22	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
but	NULL
cell	NULL
lysate	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
PAF	NULL
showed	NULL
no	NULL
significant	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

Staining	NULL
of	NULL
immunoblots	NULL
from	NULL
each	NULL
fraction	NULL
with	NULL
an	NULL
anti-ERK1/ERK2	NULL
antibody	NULL
confirms	NULL
that	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
elute	NULL
at	NULL
fractions	NULL
18-22	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
C	NULL
and	NULL
F	NULL
)	NULL
.	NULL

Restaining	NULL
of	NULL
the	NULL
blots	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
confirmed	NULL
specific	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
p42/	NULL
44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
corresponding	NULL
to	NULL
fractions	NULL
with	NULL
enzymatic	NULL
activity	NULL
in	NULL
cells	NULL
stimulated	NULL
by	NULL
FMLP	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Cells	NULL
stimu-	NULL
978	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

lated	NULL
with	NULL
PAF	NULL
demonstrated	NULL
trace	NULL
amounts	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
in	NULL
fractions	NULL
20-22	NULL
,	NULL
as	NULL
well	NULL
as	NULL
several	NULL
broad	NULL
bands	NULL
of	NULL
a	NULL
higher	NULL
and	NULL
lower	NULL
molecular	NULL
weight	NULL
then	NULL
p42/44	NULL
MAPk	NULL
in	NULL
fractions	NULL
18-20	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
£	NULL
)	NULL
.	NULL

An	NULL
equivalent	NULL
pattern	NULL
of	NULL
anti-phosphotyrosine	NULL
antibody	NULL
binding	NULL
is	NULL
seen	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
,	NULL
and	NULL
is	NULL
distinctly	NULL
different	NULL
from	NULL
the	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
seen	NULL
in	NULL
FMLP-stimulated	NULL
neutrophils	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
unstimulated	NULL
neutrophils	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
equivalent	NULL
amounts	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
and	NULL
p38	NULL
MAPk	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
F	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
stimulated	NULL
samples	NULL
in	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
.	NULL

However	NULL
,	NULL
no	NULL
significant	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
or	NULL
specific	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
E	NULL
)	NULL
was	NULL
present	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
stimulation	NULL
with	NULL
FMLP	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
and	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
,	NULL
while	NULL
stimulation	NULL
with	NULL
PAF	NULL
results	NULL
in	NULL
preferential	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

Concentration	NULL
dependence	NULL
of	NULL
FMLP	NULL
and	NULL
PAF	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
FMLP	NULL
and	NULL
PAF	NULL
occurs	NULL
in	NULL
a	NULL
concentration	NULL
dependent	NULL
fashion	NULL
,	NULL
human	NULL
neutrophils	NULL
were	NULL
exposed	NULL
for	NULL
90	NULL
s	NULL
with	NULL
concentrations	NULL
of	NULL
stimuli	NULL
ranging	NULL
from	NULL
10-	NULL
'	NULL
M	NULL
to	NULL
10-	NULL
``	NULL
'	NULL
M.	NULL
The	NULL
p38	NULL
MAPK	NULL
was	NULL
then	NULL
immunoprecipitated	NULL
from	NULL
lysed	NULL
cells	NULL
and	NULL
the	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
relative	NULL
amount	NULL
of	NULL
p38	NULL
MAPk	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
as	NULL
measured	NULL
by	NULL
anti-phosphotyrosine	NULL
antibody	NULL
binding	NULL
)	NULL
increased	NULL
with	NULL
increasing	NULL
concentra-	NULL
Figure	NULL
3	NULL
.	NULL

Anion	NULL
exchange	NULL
chromatography	NULL
elution	NULL
profile	NULL
of	NULL
lysates	NULL
from	NULL
unstimulated	NULL
neutrophils	NULL
demonstrating	NULL
the	NULL
absence	NULL
of	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
A	NULL
x	NULL
3	NULL
_	NULL
|	NULL
Unstimulated	NULL
3	NULL
6	NULL
E	NULL
g	NULL
5	NULL
3	NULL
S	NULL
>	NULL
2	NULL
=	NULL
Fa	NULL
€	NULL
C	NULL
1	NULL
1	NULL
I	NULL
t	NULL
L	NULL
t	NULL
1	NULL
1	NULL
t	NULL
u	NULL
T	NULL
T	NULL
t	NULL
u	NULL
T	NULL
YO	NULL
t	NULL
T	NULL
T	NULL
``	NULL
Uo	NULL
5	NULL
w	NULL
;	NULL
w	NULL
B	NULL
anti-PY	NULL
%	NULL
C	NULL
__	NULL
anti-	NULL
MAPK	NULL
cs	NULL
30	NULL
&	NULL
.	NULL

D	NULL
Les	NULL
z	NULL
28	NULL
Unstimulated	NULL
55	NULL
»	NULL
2	NULL
p	NULL
3	NULL
gis	NULL
E	NULL
:	NULL
F	NULL
45	NULL
10	NULL
§	NULL
%	NULL
€	NULL
.	NULL

0	NULL
~	NULL
us	NULL
.	NULL

w	NULL
E	NULL
anti-PY	NULL
anti-p38	NULL
C	NULL
2	NULL
3	NULL
4	NULL
S	NULL
6	NULL
1708	NULL
9IIUII	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
20	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
Fraction	NULL
Number	NULL
kinases	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinase	NULL
from	NULL
unstimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
P	NULL
into	NULL
EGFReq-ey1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
unstimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
A	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Immunoblots	NULL
of	NULL
each	NULL
Mono-Q	NULL
fraction	NULL
corresponding	NULL
to	NULL
the	NULL
activity	NULL
plot	NULL
above	NULL
.	NULL

A	NULL
band	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
«	NULL
-	NULL
»	NULL
d	NULL
-	NULL
higher	NULL
molecular	NULL
weight	NULL
than	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
k	NULL
is	NULL
seen	NULL
in	NULL
fractions	NULL
18-21	NULL
,	NULL
and	NULL
of	NULL
lower	NULL
molecular	NULL
weight	NULL
at	NULL
fraction	NULL
18	NULL
,	NULL
similar	NULL
to	NULL
PAF	NULL
stimulated	NULL
neutrophils	NULL
(	NULL
£	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Elution	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
from	NULL
PAF-stimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
B	NULL
were	NULL
restained	NULL
with	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localization	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
to	NULL
fractions	NULL
18-22	NULL
,	NULL
in	NULL
similar	NULL
quantities	NULL
to	NULL
cell	NULL
lysates	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
C	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
F	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAPk	NULL
from	NULL
unstimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Kinase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
P	NULL
into	NULL
recombinant	NULL
ATF-2	NULL
,	NULL
_	NULL
;	NULL
;	NULL
,	NULL
.	NULL

(	NULL
£	NULL
)	NULL
Elution	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
from	NULL
unstimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
shown	NULL
in	NULL
D	NULL
were	NULL
further	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

No	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
the	NULL
region	NULL
of	NULL
p38	NULL
MAP	NULL
k	NULL
elution	NULL
(	NULL
fractions	NULL
29-31	NULL
)	NULL
was	NULL
detected	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Elution	NULL
of	NULL
p38	NULL
MAPk	NULL
from	NULL
unstimulated	NULL
neutrophil	NULL
lysates	NULL
.	NULL

Blots	NULL
shown	NULL
in	NULL
£	NULL
were	NULL
restained	NULL
with	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
,	NULL
confirming	NULL
the	NULL
localization	NULL
of	NULL
p38	NULL
MAPk	NULL
to	NULL
fractions	NULL
29-31	NULL
,	NULL
in	NULL
similar	NULL
quantities	NULL
to	NULL
the	NULL
cell	NULL
lysate	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
F	NULL
)	NULL
.	NULL

FMLP	NULL
PAF	NULL
A	NULL
kD	NULL
0	NULL
01	NULL
Uf	NULL
£	NULL
10100	NULL
0	NULL
.01	NULL
1	NULL
1	NULL
10	NULL
100	NULL
50	NULL
i+	NULL
#	NULL
G	NULL
tase	NULL
wa	NULL
ag	NULL
@	NULL
P	NULL
\	NULL
=	NULL
--	NULL
p38	NULL
MAPK	NULL
35	NULL
B	NULL
6	NULL
Activity	NULL
(	NULL
fold	NULL
increase	NULL
)	NULL
4n	NULL
--	NULL
-su-	NULL
0	NULL
.01	NULL
l	NULL
1	NULL
10100	NULL
0.01	NULL
.I	NULL
1	NULL
10	NULL
100	NULL
fMLP	NULL
PAF	NULL
Concentration	NULL
(	NULL
nM	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

Concentration-dependence	NULL
of	NULL
p38	NULL
MAPk	NULL
phosphorylation	NULL
and	NULL
activation	NULL
after	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
)	NULL
comparing	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
after	NULL
a	NULL
90	NULL
s	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
10~	NULL
``	NULL
M	NULL
to	NULL
10~	NULL
``	NULL
'	NULL
M	NULL
)	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
p38	NULL
MAPk	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
p38	NULL
MAPk	NULL
antisera	NULL
and	NULL
the	NULL
immunoblot	NULL
was	NULL
stained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
is	NULL
visible	NULL
after	NULL
stimulation	NULL
with	NULL
1	NULL
nM	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
both	NULL
stimuli	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
determined	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
ATF-21_110	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
activity	NULL
was	NULL
quantified	NULL
tions	NULL
of	NULL
both	NULL
FMLP	NULL
and	NULL
PAF	NULL
in	NULL
a	NULL
roughly	NULL
equivalent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
p38	NULL
MAPk	NULL
enzymatic	NULL
activity	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
P	NULL
phosphorylation	NULL
of	NULL
ATF-211	NULL
;	NULL
,	NULL
increased	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Restaining	NULL
of	NULL
the	NULL
blot	NULL
from	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
with	NULL
an	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
confirmed	NULL
equal	NULL
amounts	NULL
of	NULL
enzyme	NULL
were	NULL
immunoprecipitated	NULL
in	NULL
each	NULL
sample	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
p38	NULL
MAPK	NULL
activation	NULL
and	NULL
phosphorylation	NULL
after	NULL
exposure	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAP	NULL
k	NULL
after	NULL
stimulation	NULL
with	NULL
FMLP	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
neutrophil	NULL
cell	NULL
lysates	NULL
with	NULL
p38	NULL
MAPk	NULL
antisera	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
was	NULL
measured	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
ATF-2	NULL
j	NULL
,	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
is	NULL
greatest	NULL
at	NULL
~	NULL
90	NULL
s	NULL
,	NULL
while	NULL
the	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
PAF	NULL
stimulated	NULL
cells	NULL
peaks	NULL
at	NULL
about	NULL
120	NULL
s	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
p38	NULL
MAPk	NULL
activity	NULL
is	NULL
seen	NULL
to	NULL
closely	NULL
reflect	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
.	NULL

All	NULL
blots	NULL
were	NULL
restained	NULL
with	NULL
an	NULL
anti-p38	NULL
MAPk	NULL
antibody	NULL
to	NULL
confirm	NULL
equal	NULL
amounts	NULL
of	NULL
enzyme	NULL
were	NULL
immunoprecipitated	NULL
during	NULL
the	NULL
separation	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
phosphorimaging	NULL
of	NULL
autoradiographs	NULL
.	NULL

The	NULL
plot	NULL
shows	NULL
the	NULL
activity	NULL
expressed	NULL
as	NULL
a	NULL
fold	NULL
increase	NULL
over	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
unstimulated	NULL
cell	NULL
for	NULL
each	NULL
concentration	NULL
,	NULL
and	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
979	NULL
%	NULL
FMLP	NULL
U	NULL
PAF	NULL
A	NULL
kDa	NULL
Sinn	NULL
\	NULL
40	NULL
-=	NULL
8	NULL
K	NULL
E	NULL
E	NULL
C	NULL
6	NULL
a	NULL
H	NULL
B	NULL
@	NULL
P	NULL
_	NULL
pis	NULL
ark	NULL
35	NULL
B	NULL
40-_	NULL
--	NULL
@	NULL
@	NULL
GB®B	NULL
-	NULL
pus	NULL
vars	NULL
35	NULL
--	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120600	NULL
600	NULL
30	NULL
60	NULL
90	NULL
120	NULL
600	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
15	NULL
7	NULL
7	NULL
C	NULL
I	NULL
FMLP	NULL
PAF	NULL
AN	NULL
11	NULL
}	NULL
``	NULL
100	NULL
||	NULL
Activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
\	NULL
FI—	NULL
_|_|_|_	NULL
”	NULL
T—'I__	NULL
‘	NULL
(	NULL
600	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
600	NULL
Time	NULL
(	NULL
see	NULL
)	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
p38	NULL
MAPk	NULL
phosphorylation	NULL
and	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
representative	NULL
immunoblot	NULL
of	NULL
cell	NULL
lysates	NULL
after	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
for	NULL
a	NULL
range	NULL
of	NULL
time	NULL
intervals	NULL
compared	NULL
to	NULL
cells	NULL
left	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAPk	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
p38	NULL
MAPk	NULL
antisera	NULL
,	NULL
and	NULL
the	NULL
immunoblot	NULL
stained	NULL
with	NULL
an	NULL
anti-p38	NULL
antibody	NULL
,	NULL
demonstrating	NULL
equivalent	NULL
amounts	NULL
of	NULL
p38	NULL
MAPk	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Restaining	NULL
of	NULL
the	NULL
above	NULL
immunoblot	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
to	NULL
probe	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
kinase	NULL
.	NULL

Maximal	NULL
p38	NULL
MAPk	NULL
phosphorylation	NULL
is	NULL
seen	NULL
within	NULL
90	NULL
to	NULL
120	NULL
s	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
determined	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
ATF-2	NULL
;	NULL
_i	NULL
,	NULL
for	NULL
each	NULL
time	NULL
point	NULL
,	NULL
and	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
of	NULL
an	NULL
autoradiograph	NULL
.	NULL

The	NULL
plot	NULL
shows	NULL
the	NULL
activity	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
for	NULL
each	NULL
time	NULL
interval	NULL
,	NULL
and	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

Maximal	NULL
activity	NULL
of	NULL
p38	NULL
MAP	NULL
k	NULL
is	NULL
seen	NULL
at	NULL
approximately	NULL
90	NULL
s	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
FMLP	NULL
or	NULL
PAF	NULL
,	NULL
corresponding	NULL
closely	NULL
with	NULL
the	NULL
time	NULL
course	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
shown	NULL
in	NULL
B.	NULL
from	NULL
the	NULL
cell	NULL
lysate	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

Together	NULL
the	NULL
results	NULL
from	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
demonstrate	NULL
that	NULL
FMLP	NULL
and	NULL
PAF	NULL
have	NULL
equivalent	NULL
capacity	NULL
to	NULL
induce	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

Concentration	NULL
dependence	NULL
of	NULL
FMLP	NULL
and	NULL
PAF	NULL
activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
.	NULL

The	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
was	NULL
also	NULL
determined	NULL
after	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
a	NULL
range	NULL
of	NULL
FMLP	NULL
and	NULL
PAF	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

FMLP	NULL
was	NULL
found	NULL
to	NULL
be	NULL
a	NULL
significantly	NULL
more	NULL
potent	NULL
activator	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
than	NULL
PAF	NULL
at	NULL
each	NULL
concentration	NULL
tested	NULL
.	NULL

The	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
was	NULL
relatively	NULL
greater	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
FMLP	NULL
(	NULL
but	NULL
not	NULL
PAF	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
kinase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

Some	NULL
activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
was	NULL
detected	NULL
in	NULL
cells	NULL
980	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

MLP	NULL
PAF	NULL
0	NULL
b	NULL
10	NULL
100	NULL
0	NULL
i_	NULL
10	NULL
100	NULL
kD	NULL
A	NULL
50	NULL
--	NULL
-	NULL
-	NULL
o-	NULL
«	NULL
t	NULL
im	NULL
TA	NULL
D	NULL
a	NULL
»	NULL
to	NULL
io	NULL
Fo	NULL
<	NULL
4-	NULL
p42/44M	NULL
APK	NULL
B	NULL
50	NULL
«	NULL
ib	NULL
a	NULL
»	NULL
dip	NULL
Op	NULL
«	NULL
=~	NULL
~-	NULL
~-	NULL
~*	NULL
<	NULL
4-p42/44MAPK	NULL
C	NULL
1107	NULL
100-4	NULL
I	NULL
&	NULL
904	NULL
.	NULL

>	NULL
e	NULL
804	NULL
E	NULL
104	NULL
9	NULL
&	NULL
6047	NULL
8	NULL
504	NULL
g	NULL
404	NULL
a	NULL
304	NULL
4	NULL
&	NULL
204	NULL
he	NULL
T	NULL
<	NULL
a	NULL
104	NULL
a-	NULL
``	NULL
a	NULL
_I	NULL
10	NULL
100	NULL
o_	NULL
i	NULL
i0	NULL
100	NULL
fMLP	NULL
PAF	NULL
Concentration	NULL
(	NULL
nM	NULL
)	NULL
Figure	NULL
6	NULL
.	NULL

Concentration	NULL
dependence	NULL
of	NULL
FMLP	NULL
and	NULL
PAF	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
p42/44	NULL
MAPk	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
)	NULL
comparing	NULL
the	NULL
amount	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
after	NULL
a	NULL
90	NULL
s	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
10-	NULL
'	NULL
M	NULL
to	NULL
10~°	NULL
M	NULL
)	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
immunoblot	NULL
was	NULL
stained	NULL
with	NULL
a	NULL
different	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
were	NULL
immunoprecipitated	NULL
for	NULL
each	NULL
condition	NULL
tested	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
)	NULL
comparing	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
after	NULL
a	NULL
90	NULL
s	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
10~	NULL
'	NULL
M	NULL
to	NULL
10~°	NULL
M	NULL
)	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

The	NULL
immunoblot	NULL
shown	NULL
in	NULL
A	NULL
was	NULL
restained	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
is	NULL
visibly	NULL
increased	NULL
after	NULL
stimulation	NULL
with	NULL
10	NULL
nM	NULL
(	NULL
107°	NULL
M	NULL
)	NULL
FMLP	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
.	NULL

No	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
seen	NULL
after	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
by	NULL
PAF	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
after	NULL
a	NULL
90	NULL
s	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
10	NULL
M	NULL
to	NULL
10~	NULL
``	NULL
'	NULL
M	NULL
)	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
,	NULL
corresponding	NULL
to	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
was	NULL
determined	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
EGFRe	NULL
,	NULL
,	NULL
_,5	NULL
,	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
stimuli	NULL
.	NULL

The	NULL
plot	NULL
shows	NULL
activity	NULL
expressed	NULL
as	NULL
counts	NULL
per	NULL
minute	NULL
(	NULL
CPM	NULL
)	NULL
and	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

stimulated	NULL
with	NULL
10-	NULL
'	NULL
M	NULL
PAF	NULL
,	NULL
corresponding	NULL
approximately	NULL
to	NULL
the	NULL
activation	NULL
induced	NULL
by	NULL
a	NULL
100-fold	NULL
lower	NULL
concentration	NULL
of	NULL
FMLP	NULL
.	NULL

Restaining	NULL
of	NULL
the	NULL
immunoblot	NULL
with	NULL
an	NULL
anti-ERK	NULL
MAPk	NULL
antibody	NULL
demonstrates	NULL
equal	NULL
amounts	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
were	NULL
immunoprecipitated	NULL
for	NULL
each	NULL
condition	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
activation	NULL
after	NULL
exposure	NULL
to	NULL
FMLP	NULL
and	NULL
PAF	NULL
.	NULL

Activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
after	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
occur	NULL
in	NULL
a	NULL
time	NULL
and	NULL
dose	NULL
dependent	NULL
manner	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
in	NULL
human	NULL
neutrophils	NULL
is	NULL
not	NULL
activated	NULL
after	NULL
90	NULL
s	NULL
of	NULL
exposure	NULL
to	NULL
PAF	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PAF	NULL
results	NULL
in	NULL
a	NULL
delayed	NULL
activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
,	NULL
neutrophils	NULL
were	NULL
exposed	NULL
to	NULL
either	NULL
FMLP	NULL
or	NULL
PAF	NULL
over	NULL
a	NULL
range	NULL
of	NULL
time	NULL
intervals	NULL
807	NULL
707	NULL
T	NULL
so-	NULL
T	NULL
1	NULL
I	NULL
so-	NULL
mil	NULL
|	NULL
40	NULL
MAP	NULL
kinase	NULL
activity	NULL
(	NULL
cpm	NULL
x10	NULL
)	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
1	NULL
0	NULL
O1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
70	NULL
8	NULL
9	NULL
10	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
7	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
p42/44	NULL
MAPk	NULL
activation	NULL
.	NULL

Neutrophils	NULL
stimulated	NULL
with	NULL
10	NULL
M	NULL
FMLP	NULL
(	NULL
EM	NULL
)	NULL
or	NULL
10	NULL
M	NULL
PAF	NULL
(	NULL
O	NULL
)	NULL
over	NULL
a	NULL
range	NULL
of	NULL
time	NULL
intervals	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
antibody	NULL
.	NULL

Kinase	NULL
activity	NULL
for	NULL
each	NULL
sample	NULL
was	NULL
determined	NULL
by	NULL
P	NULL
phosphorylation	NULL
of	NULL
EGFReq-45	NULL
;	NULL
.	NULL

The	NULL
plot	NULL
shows	NULL
activity	NULL
expressed	NULL
as	NULL
CPM	NULL
for	NULL
each	NULL
time	NULL
interval	NULL
,	NULL
and	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
30	NULL
s	NULL
to	NULL
10	NULL
min	NULL
)	NULL
using	NULL
a	NULL
concentration	NULL
shown	NULL
to	NULL
induce	NULL
detectable	NULL
activation	NULL
for	NULL
both	NULL
(	NULL
10	NULL
M	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

At	NULL
all	NULL
times	NULL
indi-cated	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
by	NULL
FMLP	NULL
is	NULL
significantly	NULL
greater	NULL
than	NULL
the	NULL
activity	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
PAF	NULL
.	NULL

Both	NULL
chemoattractants	NULL
achieve	NULL
maximal	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
phosphorylation	NULL
of	NULL
EGFRsyq-4s	NULL
,	NULL
within	NULL
2	NULL
min	NULL
,	NULL
but	NULL
the	NULL
relatively	NULL
small	NULL
PAF	NULL
induced	NULL
response	NULL
declines	NULL
thereafter	NULL
,	NULL
while	NULL
the	NULL
response	NULL
to	NULL
FMLP	NULL
is	NULL
maintained	NULL
through	NULL
10	NULL
min	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
results	NULL
from	NULL
Figs	NULL
.	NULL

2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
demonstrate	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
results	NULL
in	NULL
significantly	NULL
greater	NULL
activation	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
then	NULL
does	NULL
PAF	NULL
over	NULL
the	NULL
identical	NULL
range	NULL
of	NULL
stimuli	NULL
concentration	NULL
and	NULL
time	NULL
intervals	NULL
.	NULL

Activation	NULL
of	NULL
MKK3	NULL
after	NULL
exposure	NULL
of	NULL
human	NULL
neutrophils	NULL
to	NULL
FMLP	NULL
and	NULL
PAF	NULL
.	NULL

Two	NULL
recently	NULL
cloned	NULL
human	NULL
MAP	NULL
kinase	NULL
kinases	NULL
(	NULL
MKK3	NULL
and	NULL
MKK4	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
and	NULL
activate	NULL
p38	NULL
MAPk	NULL
(	NULL
but	NULL
not	NULL
p42/44	NULL
[	NULL
ERK	NULL
]	NULL
MAPK	NULL
)	NULL
when	NULL
overexpressed	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
MKK3	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
after	NULL
exposure	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
,	NULL
we	NULL
expressed	NULL
recombinant	NULL
human	NULL
kinase	NULL
active	NULL
p38	NULL
MAPk	NULL
,	NULL
,	NULL
and	NULL
inactive	NULL
p38	NULL
MAPK	NULL
,	NULL
,	NULL
forms	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

These	NULL
were	NULL
utilized	NULL
as	NULL
substrates	NULL
for	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
which	NULL
immunoprecipitated	NULL
MKK3	NULL
was	NULL
incubated	NULL
with	NULL
p38	NULL
MAP	NULL
k	NULL
;	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
followed	NULL
by	NULL
separation	NULL
with	NULL
SDS-PAGE	NULL
.	NULL

Neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
demonstrated	NULL
equivalent	NULL
amounts	NULL
of	NULL
MKK3	NULL
activation	NULL
as	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
of	NULL
°P	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
,	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
C	NULL
)	NULL
and	NULL
in	NULL
a	NULL
representative	NULL
autoradiograph	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
)	NULL
.	NULL

Restaining	NULL
of	NULL
the	NULL
immunoblot	NULL
with	NULL
an	NULL
anti-MKK3	NULL
antibody	NULL
confirms	NULL
equal	NULL
amounts	NULL
of	NULL
MKK3	NULL
were	NULL
immunoprecipitated	NULL
for	NULL
each	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
FMLP	NULL
is	NULL
capable	NULL
of	NULL
significant	NULL
activation	NULL
of	NULL
MEK1/MEK2	NULL
,	NULL
but	NULL
PAF	NULL
stimulation	NULL
results	NULL
in	NULL
only	NULL
slight	NULL
activation	NULL
of	NULL
MEK1	NULL
and	NULL
negligible	NULL
activation	NULL
of	NULL
MEK2	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

>	NULL
38	NULL
«	NULL
&	NULL
%	NULL
z	NULL
&	NULL
a	NULL
kD	NULL
Q	NULL
?	NULL

(	NULL
g	NULL
?	NULL

q	NULL
?	NULL

A	NULL
48	NULL
--	NULL
hes	NULL
``	NULL
ma	NULL
z	NULL
l	NULL
l	NULL
MKK3	NULL
50	NULL
e	NULL
B	NULL
somme	NULL
.	NULL

@	NULL
b	NULL
Alie	NULL
-	NULL
p38	NULL
MAPK	NULL
)	NULL
.	NULL

,	NULL
40	NULL
-	NULL
.	NULL

3.0	NULL
7	NULL
4	NULL
to	NULL
n	NULL
a	NULL
--	NULL
-4+4	NULL
Activity	NULL
(	NULL
fold	NULL
increase	NULL
)	NULL
-	NULL
DJ	NULL
n	NULL
o	NULL
U	NULL
__FE	NULL
_P	NULL
Figure	NULL
8	NULL
.	NULL

Activation	NULL
of	NULL
MKK3	NULL
by	NULL
FMLP	NULL
or	NULL
PAF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
)	NULL
of	NULL
MKK3	NULL
immunoprecipitated	NULL
from	NULL
human	NULL
neutrophils	NULL
after	NULL
a	NULL
90	NULL
s	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
FMLP	NULL
(	NULL
107	NULL
%	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
107	NULL
%	NULL
M	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
an	NULL
unstimulated	NULL
sample	NULL
.	NULL

The	NULL
immunoblot	NULL
was	NULL
stained	NULL
with	NULL
a	NULL
second	NULL
anti-MKK3	NULL
antibody	NULL
to	NULL
demonstrate	NULL
equivalent	NULL
amounts	NULL
of	NULL
MKK3	NULL
immunoprecipitated	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiograph	NULL
comparing	NULL
*P	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
;	NULL
,	NULL
,	NULL
,	NULL
by	NULL
MKK3	NULL
immunoprecipitated	NULL
in	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Activity	NULL
of	NULL
MKK3	NULL
as	NULL
determined	NULL
by	NULL
P	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAP	NULL
k	NULL
;	NULL
,	NULL
in	NULL
cell	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
F	NULL
)	NULL
,	NULL
PAF	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
was	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
of	NULL
autoradiographs	NULL
.	NULL

The	NULL
plot	NULL
shows	NULL
the	NULL
activity	NULL
expressed	NULL
as	NULL
a	NULL
fold	NULL
increase	NULL
over	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
unstimulated	NULL
cell	NULL
for	NULL
each	NULL
condition	NULL
,	NULL
and	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

PAF	NULL
weakly	NULL
activates	NULL
Raf	NULL
and	NULL
MEKK1I	NULL
.	NULL

The	NULL
chemoattractant	NULL
FMLP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
robustly	NULL
activate	NULL
both	NULL
C-Raf-1	NULL
and	NULL
B-Raf	NULL
in	NULL
a	NULL
time	NULL
dependent	NULL
manner	NULL
(	NULL
16	NULL
)	NULL
.	NULL

We	NULL
questioned	NULL
whether	NULL
PAF	NULL
would	NULL
similarly	NULL
activate	NULL
c-Raf-1	NULL
.	NULL

Neutrophils	NULL
were	NULL
stimulated	NULL
by	NULL
either	NULL
PAF	NULL
or	NULL
FMLP	NULL
for	NULL
varying	NULL
time	NULL
intervals	NULL
and	NULL
lysates	NULL
immunoprecipitated	NULL
by	NULL
anti-c-Raf-1	NULL
antise-rum	NULL
.	NULL

Activation	NULL
of	NULL
Raf	NULL
was	NULL
determined	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
in	NULL
which	NULL
P	NULL
phosphorylation	NULL
of	NULL
the	NULL
substrate	NULL
MEK	NULL
;	NULL
,	NULL
,	NULL
was	NULL
qualified	NULL
by	NULL
autoradiography	NULL
after	NULL
separation	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
A	NULL
,	NULL
PAF	NULL
(	NULL
107	NULL
M	NULL
)	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
induces	NULL
slight	NULL
activation	NULL
of	NULL
c-Raf-1	NULL
,	NULL
resulting	NULL
in	NULL
weak	NULL
phosphorylation	NULL
of	NULL
MEK	NULL
I	NULL
;	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
107	NULL
M	NULL
)	NULL
for	NULL
60	NULL
s.	NULL
Raf	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
occurs	NULL
within	NULL
30	NULL
s	NULL
,	NULL
is	NULL
optimal	NULL
by	NULL
2	NULL
min	NULL
and	NULL
plateaus	NULL
over	NULL
a	NULL
5-min	NULL
interval	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
appears	NULL
to	NULL
be	NULL
delayed	NULL
and	NULL
of	NULL
a	NULL
much	NULL
lesser	NULL
magnitude	NULL
,	NULL
when	NULL
compared	NULL
with	NULL
FMLP	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
in	NULL
FMLP	NULL
stimulated	NULL
neutrophils	NULL
,	NULL
MEKK1	NULL
is	NULL
activated	NULL
and	NULL
in	NULL
turn	NULL
phosphorylates	NULL
a	NULL
recombinant	NULL
human	NULL
kinase	NULL
inactive	NULL
MEK	NULL
1L	NULL
,	NULL
,	NULL
,	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
PAF	NULL
stimulation	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
MEKK1	NULL
was	NULL
tested	NULL
in	NULL
an	NULL
identical	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
B	NULL
)	NULL
.	NULL

PAF	NULL
stimulated	NULL
neutrophils	NULL
show	NULL
slightly	NULL
enhanced	NULL
MEKK1	NULL
activity	NULL
as	NULL
determined	NULL
by	NULL
phosphorylation	NULL
of	NULL
MEK	NULL
However	NULL
,	NULL
this	NULL
activity	NULL
is	NULL
meager	NULL
Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
981	NULL
c-Raf-1	NULL
MEK	NULL
,	NULL
,	NULL
_U	NULL
MLP	NULL
PAF	NULL
’	NULL
.	NULL

«	NULL
--	NULL
l	NULL
a-	NULL
MEK	NULL
!	NULL

..	NULL
,	NULL
60	NULL
60	NULL
30	NULL
4s	NULL
60	NULL
90	NULL
120	NULL
300	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
60	NULL
120	NULL
30	NULL
60	NULL
120	NULL
300	NULL
Figure	NULL
9	NULL
.	NULL

Effect	NULL
of	NULL
FMLP	NULL
or	NULL
PAF	NULL
stimulation	NULL
on	NULL
MEKK1	NULL
RAF	NULL
and	NULL
MEKK1	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
U	NULL
fMLP	NULL
PAF	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
)	NULL
CX	NULL
i	NULL
comparing	NULL
activation	NULL
of	NULL
i	NULL
<	NULL
4-MEEKl	NULL
jo	NULL
,	NULL
c-Raf-1	NULL
after	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
by	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

Activation	NULL
of	NULL
c-Raf-1	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10-	NULL
``	NULL
M	NULL
)	NULL
for	NULL
60	NULL
s	NULL
was	NULL
compared	NULL
to	NULL
cells	NULL
stimu-	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
lated	NULL
with	NULL
PAF	NULL
(	NULL
10-	NULL
M	NULL
)	NULL
over	NULL
a	NULL
range	NULL
of	NULL
times	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
.	NULL

Activity	NULL
was	NULL
determined	NULL
by	NULL
P	NULL
phosphorylation	NULL
of	NULL
MEK	NULL
11	NULL
,	NULL
,	NULL
,	NULL
,	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
viewed	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiograph	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
)	NULL
comparing	NULL
activation	NULL
of	NULL
MEKK1	NULL
after	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
by	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

Activation	NULL
of	NULL
MEKK1	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10-	NULL
'	NULL
M	NULL
)	NULL
for	NULL
120	NULL
s	NULL
was	NULL
compared	NULL
with	NULL
cells	NULL
stimulated	NULL
with	NULL
PAF	NULL
(	NULL
10-	NULL
``	NULL
M	NULL
)	NULL
over	NULL
a	NULL
range	NULL
of	NULL
times	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
.	NULL

Activity	NULL
was	NULL
determined	NULL
by	NULL
P	NULL
phosphorylation	NULL
of	NULL
MEK	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
viewed	NULL
by	NULL
autoradiography	NULL
.	NULL

in	NULL
comparison	NULL
to	NULL
that	NULL
of	NULL
induction	NULL
by	NULL
FMLP	NULL
and	NULL
follows	NULL
the	NULL
pattern	NULL
of	NULL
c-Raf-1	NULL
activation	NULL
.	NULL

Effect	NULL
of	NULL
pertussis	NULL
toxin	NULL
preincubation	NULL
on	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
after	NULL
stimulation	NULL
with	NULL
PAF	NULL
or	NULL
FMLP	NULL
.	NULL

Neutrophils	NULL
A	NULL
20	NULL
40	NULL
lj	NULL
I	NULL
JTJ	NULL
[	NULL
_	NULL
]	NULL
without	NULL
PTX	NULL
Activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
FH	NULL
[	NULL
-	NULL
]	NULL
-	NULL
without	NULL
PTX	NULL
60	NULL
-	NULL
N	NULL
with	NULL
PTX	NULL
40	NULL
Activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
20	NULL
-	NULL
=	NULL
o	NULL
-	NULL
--	NULL
--	NULL
peeeem	NULL
__	NULL
U	NULL
F	NULL
Figure	NULL
10	NULL
.	NULL

Effect	NULL
of	NULL
PTX	NULL
on	NULL
p38	NULL
MAPk	NULL
and	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activity	NULL
of	NULL
p38	NULL
MAPK	NULL
from	NULL
neutrophils	NULL
incubated	NULL
in	NULL
PTX	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
10°	NULL
M	NULL
FMLP	NULL
(	NULL
F	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
P	NULL
)	NULL
for	NULL
60	NULL
and	NULL
120	NULL
s	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
compared	NULL
to	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
cells	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Neutrophils	NULL
incubated	NULL
in	NULL
PTX	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
for	NULL
90	NULL
s.	NULL
P42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
Each	NULL
value	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

982	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pertussis	NULL
toxin	NULL
(	NULL
PTX	NULL
)	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
G	NULL
,	NULL
,	NULL
,	NULL
and	NULL
G	NULL
,	NULL
,	NULL
;	NULL
(	NULL
«	NULL
subunits	NULL
of	NULL
heterotrimeric	NULL
G-proteins	NULL
)	NULL
,	NULL
were	NULL
compared	NULL
with	NULL
neutrophils	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PTX	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
p38	NULL
MAPk	NULL
was	NULL
not	NULL
clearly	NULL
suppressed	NULL
by	NULL
PTX	NULL
pre-incubation	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
A	NULL
)	NULL
.	NULL

Simultaneously	NULL
,	NULL
neutrophils	NULL
incubated	NULL
with	NULL
PTX	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
FMLP	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
significant	NULL
inhibition	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
B	NULL
)	NULL
.	NULL

A	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
in	NULL
unstimulated	NULL
samples	NULL
was	NULL
noted	NULL
for	NULL
both	NULL
neutrophils	NULL
incubated	NULL
with	NULL
PTX	NULL
as	NULL
well	NULL
as	NULL
those	NULL
incubated	NULL
in	NULL
buffer	NULL
,	NULL
due	NULL
to	NULL
non-specific	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
prolonged	NULL
incubation	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
substantial	NULL
p38	NULL
MAPk	NULL
activation	NULL
occurs	NULL
through	NULL
a	NULL
pertussis	NULL
toxin-insensitive	NULL
pathway	NULL
.	NULL

Effect	NULL
of	NULL
p38	NULL
MAPK	NULL
inhibition	NULL
on	NULL
neutrophil	NULL
responses	NULL
after	NULL
stimulation	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

A	NULL
bicyclic	NULL
imidazole	NULL
,	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
,	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
class	NULL
of	NULL
compounds	NULL
that	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
specifically	NULL
inhibit	NULL
p38	NULL
MAPk	NULL
activity	NULL
with	NULL
negligible	NULL
effect	NULL
on	NULL
other	NULL
MAP	NULL
kinase	NULL
members	NULL
,	NULL
MEK1	NULL
,	NULL
or	NULL
c-Raf	NULL
(	NULL
34-36	NULL
)	NULL
.	NULL

Immunoprecipitated	NULL
p38	NULL
MAPk	NULL
from	NULL
PAF	NULL
or	NULL
FMLP	NULL
activated	NULL
neutrophils	NULL
was	NULL
inhibited	NULL
in	NULL
a	NULL
concentration	NULL
dependent	NULL
manner	NULL
by	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
with	NULL
a	NULL
greater	NULL
then	NULL
95	NULL
%	NULL
decrease	NULL
in	NULL
activity	NULL
at	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
inhibitor	NULL
studied	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
after	NULL
FMLP	NULL
stimulation	NULL
showed	NULL
~	NULL
20	NULL
%	NULL
reduction	NULL
of	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
uM	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
A	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
equivalent	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
studied	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirming	NULL
earlier	NULL
reports	NULL
that	NULL
this	NULL
compound	NULL
does	NULL
not	NULL
inhibit	NULL
``	NULL
upstream	NULL
``	NULL
activators	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

Neutrophils	NULL
incubated	NULL
in	NULL
identical	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
M	NULL
)	NULL
for	NULL
60	NULL
min	NULL
demonstrated	NULL
a	NULL
concentration	NULL
dependent	NULL
loss	NULL
of	NULL
superoxide	NULL
anion	NULL
production	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
FMLP	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
B	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
a	NULL
direct	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
respiratory	NULL
burst	NULL
in	NULL
neutrophils	NULL
independent	NULL
of	NULL
mechanisms	NULL
utilized	NULL
by	NULL
FMLP	NULL
(	NULL
37	NULL
)	NULL
.	NULL

PMA-induced	NULL
superoxide	NULL
anion	NULL
release	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
,	NULL
demonstrating	NULL
that	NULL
pretreatment	NULL
with	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
does	NULL
not	NULL
result	NULL
in	NULL
a	NULL
nonspecific	NULL
loss	NULL
of	NULL
the	NULL
respiratory	NULL
burst	NULL
or	NULL
decreased	NULL
cellular	NULL
activity	NULL
.	NULL

PAF	NULL
stimulated	NULL
neutrophils	NULL
produce	NULL
little	NULL
superoxide	NULL
anion	NULL
under	NULL
physiologic	NULL
conditions	NULL
,	NULL
and	NULL
preincubation	NULL
with	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
did	NULL
not	NULL
affect	NULL
this	NULL
response	NULL
so	NULL
A	NULL
B	NULL
prs	NULL
mark	NULL
D	NULL
A12	NULL
MB	NULL
Chomonxis	NULL
F	NULL
C	NULL
|	NULL
pe2/d4	NULL
(	NULL
BRK	NULL
)	NULL
MAP	NULL
E10	NULL
Chemokinesis	NULL
4	NULL
0	NULL
bs	NULL
T	NULL
j	NULL
5	NULL
,	NULL
B	NULL
30	NULL
5	NULL
€	NULL
£	NULL
§	NULL
3°	NULL
3.20	NULL
8	NULL
B	NULL
§4	NULL
<	NULL
10	NULL
B	NULL
P	NULL
2	NULL
o	NULL
B	NULL
0	NULL
ol	NULL
1	NULL
-do	NULL
0	NULL
10	NULL
SK	NULL
&	NULL
PF	NULL
86002	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
Pa	NULL
S	NULL
&	NULL
60	NULL
&	NULL
4	NULL
&	NULL
$	NULL
3	NULL
3	NULL
E	NULL
§	NULL
ao	NULL
5	NULL
£7	NULL
$	NULL
&	NULL
g	NULL
s	NULL
2	NULL
.	NULL

E	NULL
G20	NULL
4	NULL
o	NULL
El	NULL
:	NULL
2	NULL
0	NULL
o	NULL
oi	NULL
_	NULL
to	NULL
0	NULL
or	NULL
1	NULL
_	NULL
do	NULL
SK	NULL
&	NULL
F	NULL
s6002	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
Pi	NULL
s	NULL
é	NULL
&	NULL
B	NULL
E	NULL
3	NULL
€	NULL
3	NULL
8	NULL
e	NULL
a	NULL
&	NULL
§	NULL
§	NULL
3	NULL
<	NULL
0	NULL
0.1	NULL
I	NULL
10	NULL
0	NULL
0.1	NULL
I	NULL
10	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
Figure	NULL
11	NULL
.	NULL

Effect	NULL
of	NULL
p38	NULL
MAPk	NULL
inhibition	NULL
on	NULL
functional	NULL
responses	NULL
induced	NULL
of	NULL
the	NULL
neutrophil	NULL
after	NULL
stimulation	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

P38	NULL
MAPk	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

Activity	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
measured	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
ATF-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
range	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
pM	NULL
)	NULL
.	NULL

Under	NULL
identical	NULL
conditions	NULL
,	NULL
activity	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
immunoprecipitated	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
FMLP	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
M	NULL
)	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
for	NULL
three	NULL
experiments	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
on	NULL
superoxide	NULL
anion	NULL
production	NULL
.	NULL

Neutrophils	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
in	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
M	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
10~	NULL
'M	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
superoxide	NULL
anion	NULL
released	NULL
by	NULL
stimulated	NULL
cells	NULL
in	NULL
excess	NULL
of	NULL
that	NULL
released	NULL
by	NULL
unstimulated	NULL
cells	NULL
is	NULL
expressed	NULL
in	NULL
nanomoles	NULL
(	NULL
nM	NULL
)	NULL
of	NULL
cytochrome	NULL
C	NULL
reduced	NULL
and	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
for	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
on	NULL
neutrophil	NULL
adhesion	NULL
.	NULL

Neutrophils	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
in	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
M	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
107	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
of	NULL
stimulated	NULL
neutrophil	NULL
adherence	NULL
compared	NULL
to	NULL
unstimulated	NULL
cells	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
on	NULL
chemokinesis	NULL
and	NULL
chemotaxis	NULL
.	NULL

Neutrophil	NULL
migration	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
(	NULL
2.5	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
was	NULL
analyzed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
for	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
on	NULL
actin	NULL
assembly	NULL
.	NULL

Neutrophils	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
in	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
M	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
FMLP	NULL
(	NULL
107	NULL
M	NULL
)	NULL
or	NULL
PAF	NULL
(	NULL
10-	NULL
``	NULL
M	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
fluorescence	NULL
index	NULL
(	NULL
RFI	NULL
)	NULL
of	NULL
stimulated	NULL
neutrophils	NULL
compared	NULL
to	NULL
unstimulated	NULL
cells	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
for	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
on	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
.	NULL

Maximum	NULL
[	NULL
Ca®+*	NULL
]	NULL
;	NULL
mobilization	NULL
after	NULL
FMLP	NULL
or	NULL
PAF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
incubated	NULL
in	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
0.1-10	NULL
uM	NULL
)	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
the	NULL
maximum	NULL
fMLP	NULL
PAF	NULL
Raf\	NULL
MEKK-1	NULL
MEKK-X	NULL
MEKI/MEK2	NULL
MKK-3	NULL
(	NULL
?	NULL
)	NULL

ERK1/ERK2	NULL
ap	NULL
.	NULL

p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPK	NULL
+	NULL
p38	NULL
MAP	NULL
kinase	NULL
Lo	NULL
4	NULL
nd	NULL
superoxide	NULL
anion	NULL
release	NULL
adhesion	NULL
chemotaxis	NULL
phosphorylation	NULL
of	NULL
ePLAq	NULL
Figure	NULL
12	NULL
.	NULL

Scheme	NULL
depicting	NULL
proposed	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
.	NULL

(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Pretreatment	NULL
with	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
resulted	NULL
in	NULL
significant	NULL
decrease	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
with	NULL
FMLP	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
C	NULL
)	NULL
.	NULL

Chemotaxis	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
was	NULL
significantly	NULL
inhibited	NULL
by	NULL
10	NULL
pM	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
,	NULL
while	NULL
chemokinesis	NULL
was	NULL
unchanged	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
D	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
were	NULL
observed	NULL
,	NULL
although	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
chemotaxis	NULL
and	NULL
chemokinesis	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
made	NULL
these	NULL
differences	NULL
statistically	NULL
not	NULL
significant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
with	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
did	NULL
not	NULL
result	NULL
in	NULL
substantial	NULL
changes	NULL
in	NULL
actin	NULL
assembly	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
E	NULL
)	NULL
or	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
F	NULL
)	NULL
in	NULL
response	NULL
to	NULL
either	NULL
PAF	NULL
or	NULL
FMLP	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
contributes	NULL
to	NULL
FMLP-induced	NULL
superoxide	NULL
anion	NULL
release	NULL
,	NULL
adhesion	NULL
and	NULL
chemotaxis	NULL
as	NULL
well	NULL
as	NULL
PAF-induced	NULL
adhesion	NULL
.	NULL

Discussion	NULL
The	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
or	NULL
with	NULL
PAF	NULL
occurs	NULL
via	NULL
binding	NULL
of	NULL
distinct	NULL
seven	NULL
transmembrane	NULL
G	NULL
protein-linked	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

Exposure	NULL
of	NULL
the	NULL
cell	NULL
to	NULL
FMLP	NULL
then	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Ras	NULL
,	NULL
which	NULL
activates	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
Raf	NULL
.	NULL

Ras	NULL
also	NULL
regulates	NULL
the	NULL
activation	NULL
of	NULL
MEKK-1	NULL
.	NULL

Both	NULL
MEKK-1	NULL
and	NULL
Raf	NULL
when	NULL
activated	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
and	NULL
activate	NULL
MEK1/MEK2	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
serves	NULL
to	NULL
activate	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinases	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
[	NULL
Ca®+*	NULL
]	NULL
;	NULL
mobilization	NULL
after	NULL
FMLP	NULL
or	NULL
PAF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
not	NULL
exposed	NULL
to	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
983	NULL
PAF	NULL
results	NULL
in	NULL
minor	NULL
utilization	NULL
of	NULL
this	NULL
intracellular	NULL
signaling	NULL
pathway	NULL
,	NULL
with	NULL
only	NULL
slight	NULL
activation	NULL
of	NULL
p42/p44	NULL
(	NULL
ERK	NULL
)	NULL
MAP	NULL
kinases	NULL
,	NULL
MEK1/MEK2	NULL
,	NULL
Raf	NULL
,	NULL
or	NULL
MEKK-1	NULL
.	NULL

To	NULL
a	NULL
much	NULL
greater	NULL
extent	NULL
,	NULL
intracellular	NULL
signal	NULL
transduction	NULL
after	NULL
exposure	NULL
of	NULL
the	NULL
neutrophil	NULL
to	NULL
PAF	NULL
occurs	NULL
through	NULL
a	NULL
parallel	NULL
signaling	NULL
pathway	NULL
resulting	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
MKK3	NULL
and	NULL
subsequent	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
(	NULL
Fig	NULL
.	NULL

12	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
report	NULL
that	NULL
stimulation	NULL
with	NULL
FMLP	NULL
also	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
MKK3	NULL
and	NULL
p38	NULL
MAP	NULL
k	NULL
in	NULL
a	NULL
time	NULL
and	NULL
concentration	NULL
dependent	NULL
manner	NULL
equivalent	NULL
to	NULL
PAF	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
FMLP	NULL
activation	NULL
of	NULL
the	NULL
Raf	NULL
,	NULL
MEK1/MEK2	NULL
and	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
cascade	NULL
(	NULL
16	NULL
,	NULL
38	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
appears	NULL
to	NULL
be	NULL
largely	NULL
independent	NULL
of	NULL
inhibition	NULL
by	NULL
PTX	NULL
.	NULL

Neither	NULL
FMLP	NULL
or	NULL
PAF	NULL
were	NULL
shown	NULL
to	NULL
activate	NULL
JNKs	NULL
in	NULL
the	NULL
human	NULL
neutrophil	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
FMLP	NULL
to	NULL
robustly	NULL
activate	NULL
at	NULL
least	NULL
two	NULL
members	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
family	NULL
as	NULL
opposed	NULL
to	NULL
PAF	NULL
which	NULL
predominantly	NULL
activates	NULL
p38	NULL
MAPk	NULL
is	NULL
reflected	NULL
in	NULL
a	NULL
wider	NULL
range	NULL
of	NULL
functional	NULL
responses	NULL
evoked	NULL
by	NULL
FMLP	NULL
stimulation	NULL
.	NULL

FMLP	NULL
and	NULL
PAF	NULL
induce	NULL
comparable	NULL
neutrophil	NULL
adhesion	NULL
and	NULL
actin	NULL
assembly	NULL
,	NULL
but	NULL
only	NULL
FMLP	NULL
stimulation	NULL
results	NULL
in	NULL
significant	NULL
superoxide	NULL
production	NULL
.	NULL

Through	NULL
use	NULL
of	NULL
the	NULL
specific	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
FMLP	NULL
induced	NULL
release	NULL
of	NULL
superoxide	NULL
anion	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

However	NULL
,	NULL
p38	NULL
MAPk	NULL
activation	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
relative	NULL
inability	NULL
of	NULL
PAF	NULL
stimulation	NULL
to	NULL
induce	NULL
superoxide	NULL
anion	NULL
release	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
PMA	NULL
,	NULL
(	NULL
a	NULL
direct	NULL
activator	NULL
of	NULL
PKC	NULL
,	NULL
but	NULL
a	NULL
weak	NULL
activator	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
the	NULL
human	NULL
neutrophil	NULL
(	NULL
25	NULL
)	NULL
to	NULL
induce	NULL
superoxide	NULL
release	NULL
not	NULL
inhibited	NULL
by	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
supports	NULL
the	NULL
conclusion	NULL
that	NULL
mechanisms	NULL
independent	NULL
of	NULL
p38	NULL
MAPk	NULL
activation	NULL
can	NULL
also	NULL
mediate	NULL
superoxide	NULL
anion	NULL
release	NULL
.	NULL

Both	NULL
adhesion	NULL
after	NULL
PAF	NULL
or	NULL
FMLP	NULL
stimulation	NULL
,	NULL
and	NULL
FMLP-induced	NULL
chemotaxis	NULL
were	NULL
reduced	NULL
by	NULL
p38	NULL
MAPk	NULL
inhibition	NULL
,	NULL
but	NULL
the	NULL
responses	NULL
were	NULL
not	NULL
eliminated	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
FMLP-induced	NULL
chemokinesis	NULL
,	NULL
as	NULL
well	NULL
as	NULL
actin	NULL
assembly	NULL
and	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
after	NULL
stimulation	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
specifically	NULL
inhibited	NULL
by	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
.	NULL

These	NULL
findings	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
p38	NULL
MAPk	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
adhesion	NULL
and	NULL
chemotaxis	NULL
of	NULL
the	NULL
neutrophil	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
,	NULL
but	NULL
that	NULL
other	NULL
signaling	NULL
events	NULL
are	NULL
required	NULL
as	NULL
well	NULL
.	NULL

Involvement	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
actin	NULL
assembly	NULL
,	NULL
chemokinesis	NULL
or	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
is	NULL
not	NULL
supported	NULL
by	NULL
our	NULL
data	NULL
.	NULL

Important	NULL
clues	NULL
as	NULL
to	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
in	NULL
human	NULL
neutrophils	NULL
will	NULL
come	NULL
from	NULL
determination	NULL
of	NULL
the	NULL
substrates	NULL
for	NULL
these	NULL
kinases	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
lines	NULL
,	NULL
activation	NULL
of	NULL
MAP	NULL
kinases	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
increased	NULL
transcription	NULL
,	NULL
either	NULL
directly	NULL
or	NULL
through	NULL
phosphorylation	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

However	NULL
,	NULL
the	NULL
rapid	NULL
functional	NULL
response	NULL
of	NULL
human	NULL
neutrophils	NULL
to	NULL
pro-inflammatory	NULL
stimuli	NULL
occurs	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
thus	NULL
other	NULL
substrates	NULL
are	NULL
likely	NULL
involved	NULL
.	NULL

To	NULL
date	NULL
,	NULL
several	NULL
direct	NULL
actions	NULL
of	NULL
MAP	NULL
kinases	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

Activated	NULL
p42	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
directly	NULL
phosphorylates	NULL
cytoplasmic	NULL
phospholipase	NULL
A	NULL
;	NULL
(	NULL
ecPLA	NULL
;	NULL
)	NULL
,	NULL
allowing	NULL
for	NULL
the	NULL
release	NULL
of	NULL
arachidonic	NULL
acid	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Recently	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
p38	NULL
MAPk	NULL
phosphorylates	NULL
and	NULL
activates	NULL
MAP	NULL
kinase-activated	NULL
protein	NULL
(	NULL
MAPKAP	NULL
)	NULL
kinase-2	NULL
(	NULL
36	NULL
,	NULL
41	NULL
)	NULL
and	NULL
MAPKAP	NULL
kinase-3	NULL
(	NULL
42	NULL
)	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
heat	NULL
shock	NULL
protein	NULL
(	NULL
HSP	NULL
)	NULL
27	NULL
in	NULL
certain	NULL
cell	NULL
lines	NULL
in	NULL
response	NULL
to	NULL
pro-inflammatory	NULL
stimuli	NULL
or	NULL
hyperosmotic	NULL
conditions	NULL
.	NULL

The	NULL
substrates	NULL
phosphorylated	NULL
by	NULL
p38	NULL
MAPk	NULL
in	NULL
the	NULL
neutrophil	NULL
resulting	NULL
in	NULL
superoxide	NULL
anion	NULL
release	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
chemotaxis	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

984	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

Of	NULL
considerable	NULL
interest	NULL
is	NULL
the	NULL
upstream	NULL
regulation	NULL
event	NULL
that	NULL
enables	NULL
FMLP	NULL
to	NULL
activate	NULL
parallel	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
,	NULL
while	NULL
limiting	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
to	NULL
a	NULL
single	NULL
MAP	NULL
kinase	NULL
cascade	NULL
.	NULL

One	NULL
point	NULL
of	NULL
possible	NULL
signal	NULL
divergence	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
G-proteins	NULL
linked	NULL
to	NULL
seven	NULL
transmembrane-spanning	NULL
receptors	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
utilize	NULL
the	NULL
G-protein	NULL
«	NULL
subunit	NULL
a	NULL
;	NULL
,	NULL
as	NULL
PTX	NULL
can	NULL
inhibit	NULL
the	NULL
majority	NULL
of	NULL
Raf	NULL
and	NULL
Ras	NULL
activation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Lack	NULL
of	NULL
significant	NULL
PTX	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
after	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
or	NULL
PAF	NULL
argues	NULL
for	NULL
signal	NULL
transduction	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
PTX-insensitive	NULL
G-proteins	NULL
.	NULL

The	NULL
PAF	NULL
receptor	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
PTX-insensitive	NULL
G-proteins	NULL
(	NULL
possibly	NULL
G.	NULL
,	NULL
,	NULL
and	NULL
G	NULL
,	NULL
,	NULL
)	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
PAF	NULL
receptor	NULL
transfected	NULL
in	NULL
CHO	NULL
cells	NULL
allows	NULL
for	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
PAF	NULL
stimulation	NULL
,	NULL
with	NULL
evidence	NULL
for	NULL
PAF	NULL
receptor	NULL
coupling	NULL
to	NULL
both	NULL
PTX-sensitive	NULL
and	NULL
-insensitive	NULL
G	NULL
proteins	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Early	NULL
reports	NULL
of	NULL
inhibition	NULL
of	NULL
PAF	NULL
mediated	NULL
response	NULL
by	NULL
PTX	NULL
utilized	NULL
a	NULL
30-fold	NULL
greater	NULL
concentration	NULL
of	NULL
inhibitor	NULL
than	NULL
used	NULL
here	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
reported	NULL
may	NULL
not	NULL
have	NULL
been	NULL
specific	NULL
to	NULL
G-protein	NULL
inhibition	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Complete	NULL
definition	NULL
of	NULL
the	NULL
pattern	NULL
of	NULL
MEKK	NULL
and	NULL
MKK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
FMLP	NULL
and	NULL
PAF	NULL
will	NULL
provide	NULL
important	NULL
clues	NULL
as	NULL
to	NULL
the	NULL
point	NULL
of	NULL
convergence	NULL
for	NULL
the	NULL
FMLP	NULL
and	NULL
PAF	NULL
signaling	NULL
pathway	NULL
.	NULL

Recent	NULL
identification	NULL
and	NULL
cloning	NULL
of	NULL
MKK3	NULL
and	NULL
MKK4	NULL
has	NULL
established	NULL
that	NULL
both	NULL
MKK3	NULL
and	NULL
MKK4	NULL
can	NULL
phosphorylate	NULL
recombinant	NULL
p38	NULL
MAP	NULL
k	NULL
in	NULL
vitro	NULL
(	NULL
although	NULL
MKK4	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
activating	NULL
JNK	NULL
)	NULL
.	NULL

When	NULL
MKK3	NULL
and	NULL
MKK4	NULL
were	NULL
transfected	NULL
and	NULL
overexpressed	NULL
in	NULL
COS-1	NULL
cells	NULL
a	NULL
resulting	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
was	NULL
observed	NULL
(	NULL
MKK4	NULL
overexpression	NULL
also	NULL
led	NULL
to	NULL
increased	NULL
JNK	NULL
activ-ity	NULL
)	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
human	NULL
neutrophils	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
MKK3	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
kinase	NULL
to	NULL
phosphorylate	NULL
kinase	NULL
inactive	NULL
recombinant	NULL
human	NULL
p38	NULL
MAPk	NULL
(	NULL
p38	NULL
MAPk	NULL
;	NULL
,	NULL
,	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
activated	NULL
MKK3	NULL
could	NULL
also	NULL
result	NULL
in	NULL
activation	NULL
of	NULL
wild	NULL
type	NULL
recombinant	NULL
human	NULL
p38	NULL
MAPk	NULL
(	NULL
p38	NULL
MAPk	NULL
,	NULL
,	NULL
,	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
phosphorylation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
JNK	NULL
is	NULL
not	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
FMLP	NULL
or	NULL
PAF	NULL
supports	NULL
the	NULL
suggestion	NULL
that	NULL
the	NULL
MKK	NULL
responsible	NULL
for	NULL
the	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
mammalian	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
probably	NULL
not	NULL
MKK4	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
upstream	NULL
in	NULL
the	NULL
JNK	NULL
signaling	NULL
pathway	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
relationship	NULL
of	NULL
the	NULL
MAPk	NULL
cascades	NULL
to	NULL
other	NULL
known	NULL
signaling	NULL
events	NULL
in	NULL
human	NULL
neutrophils	NULL
remains	NULL
unclear	NULL
.	NULL

Stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
FMLP	NULL
via	NULL
G	NULL
protein-coupled	NULL
receptors	NULL
results	NULL
in	NULL
rapid	NULL
activation	NULL
of	NULL
phospholipase	NULL
C	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
,	NULL
phosphatidylcholine-specific	NULL
phospholipase	NULL
D	NULL
(	NULL
51	NULL
)	NULL
,	NULL
inosi-tol-1,4,5-triphosphate	NULL
induced	NULL
mobilization	NULL
of	NULL
[	NULL
Ca	NULL
``	NULL
+	NULL
]	NULL
;	NULL
(	NULL
52	NULL
)	NULL
and	NULL
PKC	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
MAPk-family	NULL
members	NULL
(	NULL
via	NULL
MEKK	NULL
and	NULL
MEK	NULL
homologues	NULL
)	NULL
may	NULL
occur	NULL
``	NULL
downstream	NULL
``	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
phospholipase	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
PKC	NULL
or	NULL
alternatively	NULL
be	NULL
activated	NULL
in	NULL
parallel	NULL
to	NULL
earlier	NULL
described	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Important	NULL
functional	NULL
responses	NULL
such	NULL
as	NULL
activation	NULL
of	NULL
NAPDH	NULL
oxidase	NULL
leading	NULL
directly	NULL
to	NULL
superoxide	NULL
anion	NULL
production	NULL
likely	NULL
occurs	NULL
through	NULL
more	NULL
then	NULL
one	NULL
signal	NULL
transduction	NULL
pathway	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
type	NULL
and	NULL
concentration	NULL
of	NULL
stimuli	NULL
tested	NULL
.	NULL

Inhibitors	NULL
against	NULL
various	NULL
signaling	NULL
events	NULL
have	NULL
provided	NULL
clues	NULL
,	NULL
but	NULL
relative	NULL
lack	NULL
of	NULL
specificity	NULL
of	NULL
these	NULL
agents	NULL
in	NULL
vivo	NULL
limit	NULL
the	NULL
usefulness	NULL
of	NULL
these	NULL
studies	NULL
.	NULL

Systematic	NULL
elucidation	NULL
of	NULL
the	NULL
hierarchy	NULL
of	NULL
signaling	NULL
events	NULL
that	NULL
occurs	NULL
under	NULL
physiologic	NULL
conditions	NULL
in	NULL
response	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
in	NULL
neutrophils	NULL
will	NULL
present	NULL
a	NULL
formidable	NULL
challenge	NULL
,	NULL
and	NULL
will	NULL
likely	NULL
require	NULL
a	NULL
variety	NULL
of	NULL
new	NULL
techniques	NULL
,	NULL
including	NULL
genetic	NULL
manipulation	NULL
of	NULL
primary	NULL
cells	NULL
.	NULL

The	NULL
selective	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
by	NULL
different	NULL
stimuli	NULL
provides	NULL
a	NULL
framework	NULL
in	NULL
which	NULL
to	NULL
study	NULL
the	NULL
range	NULL
of	NULL
potential	NULL
neutrophil	NULL
response	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
inflam-mation	NULL
.	NULL

To	NULL
date	NULL
,	NULL
p38	NULL
MAPK	NULL
has	NULL
been	NULL
classified	NULL
as	NULL
a	NULL
``	NULL
stress	NULL
activated	NULL
``	NULL
MAP	NULL
kinase	NULL
homologue	NULL
,	NULL
as	NULL
initial	NULL
activation	NULL
was	NULL
reported	NULL
in	NULL
response	NULL
to	NULL
such	NULL
agents	NULL
as	NULL
hyperosmolarity	NULL
,	NULL
endo-toxin	NULL
,	NULL
and	NULL
TNF	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
such	NULL
stimuli	NULL
as	NULL
thrombin	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
p38	NULL
MAPk	NULL
in	NULL
platelets	NULL
(	NULL
55	NULL
)	NULL
.	NULL

This	NULL
report	NULL
of	NULL
p38	NULL
MAPk	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
chemoattractants	NULL
via	NULL
two	NULL
serpentine	NULL
receptors	NULL
establishes	NULL
that	NULL
p38	NULL
MAPk	NULL
is	NULL
widely	NULL
utilized	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
number	NULL
of	NULL
functional	NULL
responses	NULL
in	NULL
neutrophils	NULL
.	NULL

Our	NULL
findings	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
fine	NULL
regulation	NULL
of	NULL
neutrophil	NULL
activation	NULL
occurs	NULL
through	NULL
differences	NULL
in	NULL
activation	NULL
of	NULL
a	NULL
spectrum	NULL
of	NULL
signaling	NULL
pathways	NULL
.	NULL

For	NULL
each	NULL
stimuli	NULL
capable	NULL
of	NULL
a	NULL
unique	NULL
set	NULL
of	NULL
cellular	NULL
responses	NULL
,	NULL
a	NULL
distinctive	NULL
``	NULL
fingerprint	NULL
``	NULL
of	NULL
signal	NULL
protein	NULL
activation	NULL
may	NULL
exist	NULL
,	NULL
or	NULL
instead	NULL
,	NULL
various	NULL
combinations	NULL
of	NULL
signaling	NULL
pathways	NULL
may	NULL
be	NULL
used	NULL
.	NULL

Ultimately	NULL
,	NULL
through	NULL
more	NULL
complete	NULL
understanding	NULL
of	NULL
intracellular	NULL
signaling	NULL
,	NULL
sophisticated	NULL
approaches	NULL
to	NULL
selective	NULL
inflammatory	NULL
blockade	NULL
can	NULL
be	NULL
designed	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
acknowledge	NULL
the	NULL
helpful	NULL
comments	NULL
of	NULL
Dr.	NULL
Brent	NULL
Winston	NULL
and	NULL
Dr.	NULL
Kevin	NULL
Brown	NULL
.	NULL

Advice	NULL
on	NULL
techniques	NULL
in	NULL
molecular	NULL
biology	NULL
was	NULL
provided	NULL
by	NULL
James	NULL
Nichol	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
SCOR	NULL
in	NULL
ARDS	NULL
(	NULL
HL-40784	NULL
)	NULL
,	NULL
HL-34303	NULL
,	NULL
HL-09640	NULL
,	NULL
and	NULL
GM-30324	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

Pir	NULL
Gerwins	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Fulbright	NULL
Commission	NULL
,	NULL
the	NULL
Wennergren	NULL
Foundation	NULL
and	NULL
the	NULL
Swedish	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
Swedish	NULL
Cancer	NULL
Foundation	NULL
,	NULL
Swedish	NULL
Society	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
Swedish	NULL
Institute	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Webster	NULL
,	NULL
R.O	NULL
.	NULL

,	NULL
G.L	NULL
.	NULL

Larsen	NULL
,	NULL
B.C	NULL
.	NULL

Mitchell	NULL
,	NULL
A.J	NULL
.	NULL

Gains	NULL
,	NULL
and	NULL
P.M.	NULL
Henson	NULL
.	NULL

1982	NULL
.	NULL

Absence	NULL
of	NULL
inflammatory	NULL
injury	NULL
in	NULL
rabbits	NULL
challenged	NULL
intravascularly	NULL
with	NULL
complement-derived	NULL
chemotactic	NULL
factors	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

125:335-340	NULL
.	NULL

2	NULL
.	NULL

Martin	NULL
,	NULL
T.R	NULL
.	NULL

,	NULL
B.P	NULL
.	NULL

Pistorese	NULL
,	NULL
E.Y	NULL
.	NULL

Chi	NULL
,	NULL
R.B	NULL
.	NULL

Goodman	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Mat-thay	NULL
.	NULL

1989	NULL
.	NULL

Effects	NULL
of	NULL
leukotriene	NULL
B4	NULL
in	NULL
the	NULL
human	NULL
lung	NULL
:	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
into	NULL
the	NULL
alveolar	NULL
spaces	NULL
without	NULL
a	NULL
change	NULL
in	NULL
protein	NULL
permeability	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84:1609-1616	NULL
.	NULL

3	NULL
.	NULL

Schiffman	NULL
,	NULL
E.	NULL
,	NULL
B.A	NULL
.	NULL

Corcoran	NULL
,	NULL
and	NULL
S.M	NULL
.	NULL

Wahl	NULL
.	NULL

1975	NULL
.	NULL

N-formyl	NULL
methionyl	NULL
peptides	NULL
as	NULL
chemoattractants	NULL
for	NULL
leukocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

72	NULL
;	NULL
1059-1062	NULL
.	NULL

4	NULL
.	NULL

Snyder	NULL
,	NULL
F.	NULL
1995	NULL
.	NULL

Platelet-activating	NULL
factor	NULL
and	NULL
its	NULL
analogs	NULL
:	NULL
metabolic	NULL
pathways	NULL
and	NULL
related	NULL
intracellular	NULL
processes	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1254:231-249	NULL
.	NULL

5	NULL
.	NULL

Sandborg	NULL
,	NULL
R.R	NULL
.	NULL

,	NULL
and	NULL
J.E	NULL
.	NULL

Smolen	NULL
.	NULL

1988	NULL
.	NULL

Biology	NULL
of	NULL
disease	NULL
:	NULL
early	NULL
biochemical	NULL
events	NULL
in	NULL
leukocyte	NULL
activation	NULL
.	NULL

Lab	NULL
Invest	NULL
.	NULL

59:300-320	NULL
.	NULL

6	NULL
.	NULL

Goetzl	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
CK	NULL
.	NULL

Derian	NULL
,	NULL
A.I	NULL
.	NULL

Tauber	NULL
,	NULL
and	NULL
F.H	NULL
.	NULL

Valone	NULL
.	NULL

1980	NULL
.	NULL

Novel	NULL
effects	NULL
of	NULL
1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine	NULL
mediators	NULL
on	NULL
human	NULL
leukocyte	NULL
function	NULL
:	NULL
Delineation	NULL
of	NULL
the	NULL
specific	NULL
roles	NULL
of	NULL
the	NULL
acyl	NULL
substitu-ents	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

94:881-888	NULL
.	NULL

7	NULL
.	NULL

Ingraham	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
T.D	NULL
.	NULL

Coates	NULL
,	NULL
J.M	NULL
.	NULL

Allen	NULL
,	NULL
C.P	NULL
.	NULL

Higgins	NULL
,	NULL
R.L	NULL
.	NULL

Bachner	NULL
,	NULL
and	NULL
L.A.	NULL
Boxer	NULL
.	NULL

1982	NULL
.	NULL

Metabolic	NULL
,	NULL
membrane	NULL
,	NULL
and	NULL
functional	NULL
responses	NULL
of	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
to	NULL
platelet-activating	NULL
factor	NULL
.	NULL

Blood	NULL
.	NULL

59	NULL
:	NULL
1259-1266	NULL
.	NULL

8	NULL
.	NULL

Thrasher	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
N.H.	NULL
Keep	NULL
,	NULL
F.	NULL
Wientjes	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Segal	NULL
.	NULL

1994	NULL
.	NULL

Chronic	NULL
granulomatous	NULL
disease	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1227:1-24	NULL
.	NULL

9	NULL
.	NULL

Henson	NULL
,	NULL
P.M.	NULL
,	NULL
and	NULL
R.B	NULL
.	NULL

Johnston	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Tissue	NULL
injury	NULL
in	NULL
inflammation	NULL
:	NULL
oxidants	NULL
,	NULL
proteinases	NULL
,	NULL
and	NULL
cationic	NULL
proteins	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79:669-674	NULL
.	NULL

10	NULL
.	NULL

Boulay	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Tardif	NULL
,	NULL
L.	NULL
Brouchon	NULL
,	NULL
and	NULL
P.	NULL
Vignais	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
N-formylpeptide	NULL
receptor	NULL
.	NULL

Characterization	NULL
of	NULL
two	NULL
cDNA	NULL
isolates	NULL
and	NULL
evidence	NULL
for	NULL
a	NULL
new	NULL
subfamily	NULL
of	NULL
G-protein-coupled	NULL
receptors	NULL
.	NULL

Biochemistry	NULL
.	NULL

29	NULL
:	NULL
11123-11133	NULL
.	NULL

11	NULL
.	NULL

Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Z.-i	NULL
.	NULL

Honda	NULL
,	NULL
T.	NULL
Izumi	NULL
,	NULL
C.	NULL
Sakanaka	NULL
,	NULL
H.	NULL
Mutoh	NULL
,	NULL
M.	NULL
Mi	NULL
nami	NULL
,	NULL
H.	NULL
Bito	NULL
,	NULL
Y.	NULL
Seyama	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Noma	NULL
,	NULL
and	NULL
T.	NULL
Shimizu	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
platelet-activating	NULL
factor	NULL
receptor	NULL
from	NULL
human	NULL
leukocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:20400-20405	NULL
.	NULL

12	NULL
.	NULL

Kunz	NULL
,	NULL
D.	NULL
,	NULL
N.P	NULL
.	NULL

Gerard	NULL
,	NULL
and	NULL
C.	NULL
Gerard	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
human	NULL
leukocyte	NULL
platelet-activating	NULL
factor	NULL
receptor	NULL
:	NULL
cDNA	NULL
cloning	NULL
,	NULL
cell	NULL
surface	NULL
expression	NULL
,	NULL
and	NULL
construction	NULL
of	NULL
a	NULL
novel	NULL
epitope-bearing	NULL
analog	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:9101-9106	NULL
.	NULL

13	NULL
.	NULL

Avdi	NULL
,	NULL
N.	NULL
,	NULL
B.W	NULL
.	NULL

Winston	NULL
,	NULL
M.	NULL
Russel	NULL
,	NULL
S.K	NULL
.	NULL

Young	NULL
,	NULL
G.L	NULL
.	NULL

Johnson	NULL
,	NULL
and	NULL
G.S	NULL
.	NULL

Worthen	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
MEKK	NULL
by	NULL
FMLP	NULL
in	NULL
human	NULL
neutrophils	NULL
:	NULL
mapping	NULL
pathways	NULL
for	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:33598-33606	NULL
.	NULL

14	NULL
.	NULL

Thompson	NULL
,	NULL
HL	NULL
.	NULL

,	NULL
M.	NULL
Shiroo	NULL
,	NULL
and	NULL
J.	NULL
Saklatvala	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
chemotactic	NULL
factor	NULL
N-formylmethionyl-leucyl-phenylalanine	NULL
activates	NULL
microtubule-associated	NULL
protein	NULL
2	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
and	NULL
a	NULL
MAP	NULL
kinase	NULL
kinase	NULL
in	NULL
polymorphonuclear	NULL
leukocytes	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:483-488	NULL
.	NULL

15	NULL
.	NULL

Grinstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
W.	NULL
Furuya	NULL
.	NULL

1992	NULL
.	NULL

Chemoattractant-induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
microtubule-associated	NULL
protein	NULL
Kinase	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:18122-18125	NULL
.	NULL

16	NULL
.	NULL

Worthen	NULL
,	NULL
G.S	NULL
.	NULL

,	NULL
N.	NULL
Avdi	NULL
,	NULL
A.M.	NULL
Buhl	NULL
,	NULL
N.	NULL
Suzuki	NULL
,	NULL
and	NULL
G.L	NULL
.	NULL

Johnson	NULL
.	NULL

1994	NULL
.	NULL

FMLP	NULL
activates	NULL
ras	NULL
and	NULL
raf	NULL
in	NULL
human	NULL
neutrophils	NULL
:	NULL
potential	NULL
role	NULL
in	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:815-823	NULL
.	NULL

17	NULL
.	NULL

Gomez-Cambronero	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Wang	NULL
,	NULL
G.	NULL
Johnson	NULL
,	NULL
C.-K.	NULL
Huang	NULL
,	NULL
and	NULL
RL	NULL
Sha'afi	NULL
.	NULL

1991	NULL
.	NULL

Platelet-activating	NULL
factor	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:6240-6245	NULL
.	NULL

18	NULL
.	NULL

Grinstein	NULL
,	NULL
S.	NULL
,	NULL
J.R.	NULL
Butler	NULL
,	NULL
W.	NULL
Furuya	NULL
,	NULL
G.	NULL
L	NULL
'	NULL
Allemain	NULL
,	NULL
and	NULL
G.P	NULL
.	NULL

Downey	NULL
.	NULL

1994	NULL
.	NULL

Chemotactic	NULL
peptides	NULL
induce	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
MEK-1	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:19313-19320	NULL
.	NULL

19	NULL
.	NULL

Downey	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Butler	NULL
,	NULL
J.	NULL
Brumell	NULL
,	NULL
N.	NULL
Borregaard	NULL
,	NULL
L.	NULL
Kjeldsen	NULL
,	NULL
A.	NULL
Sue-A-Quan	NULL
,	NULL
and	NULL
S.	NULL
Grinstein	NULL
.	NULL

1996	NULL
.	NULL

Chemotactic	NULL
peptide-induced	NULL
activation	NULL
of	NULL
MEK-2	NULL
,	NULL
the	NULL
predominant	NULL
isoform	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

271	NULL
:	NULL
21005-21011	NULL
.	NULL

20	NULL
.	NULL

Galcheva-Gargova	NULL
,	NULL
Z.	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
I.-H.	NULL
Wu	NULL
,	NULL
and	NULL
R.J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
Osmosensing	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

265:806-811	NULL
.	NULL

21	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
I.-H.	NULL
Wu	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
1994	NULL
.	NULL

JNK1	NULL
:	NULL
A	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
.	NULL

76:1025-1037	NULL
.	NULL

22	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Lin	NULL
,	NULL
F.-X	NULL
.	NULL

Claret	NULL
,	NULL
A.	NULL
Abo	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Selective	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
signaling	NULL
cascade	NULL
and	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
by	NULL
the	NULL
small	NULL
GTPases	NULL
Rac	NULL
and	NULL
Cded2Hs	NULL
.	NULL

Cell	NULL
.	NULL

81:1147-1157	NULL
.	NULL

23	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.S	NULL
.	NULL

Rogers	NULL
,	NULL
M.	NULL
Dickens	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
R.J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
and	NULL
threonine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:7420-7426	NULL
.	NULL

24	NULL
.	NULL

Lange-Carter	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
C.M	NULL
.	NULL

Pleiman	NULL
,	NULL
A.M.	NULL
Gardner	NULL
,	NULL
K.J	NULL
.	NULL

Blumer	NULL
,	NULL
and	NULL
G.L	NULL
.	NULL

Johnson	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
divergence	NULL
in	NULL
the	NULL
MAP	NULL
kinase	NULL
regulatory	NULL
network	NULL
defined	NULL
by	NULL
MEK	NULL
kinase	NULL
and	NULL
Raf	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

260:315-319	NULL
.	NULL

25	NULL
.	NULL

Nick	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
N.J.	NULL
Avdi	NULL
,	NULL
P.	NULL
Gerwins	NULL
,	NULL
G.L	NULL
.	NULL

Johnson	NULL
,	NULL
and	NULL
G.S	NULL
.	NULL

Worthen	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
a	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
human	NULL
neutrophils	NULL
by	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:4867-4875	NULL
.	NULL

26	NULL
.	NULL

Gardner	NULL
,	NULL
A.M.	NULL
,	NULL
R.R	NULL
.	NULL

Vaillancourt	NULL
,	NULL
and	NULL
G.L	NULL
.	NULL

Johnson	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase/extracellular	NULL
signal-regulated	NULL
kinase	NULL
kinase	NULL
by	NULL
G	NULL
protein	NULL
and	NULL
tyrosine	NULL
kinase	NULL
oncoproteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:17896-17901	NULL
.	NULL

27	NULL
.	NULL

Worthen	NULL
,	NULL
G.S	NULL
.	NULL

,	NULL
N.	NULL
Avdi	NULL
,	NULL
S.	NULL
Vukajlovich	NULL
,	NULL
and	NULL
P.S	NULL
.	NULL

Tobias	NULL
.	NULL

1992	NULL
.	NULL

Neutrophil	NULL
adherence	NULL
induced	NULL
by	NULL
lipopolysaccharide	NULL
in	NULL
vitro	NULL
:	NULL
Role	NULL
of	NULL
plasma	NULL
component	NULL
interaction	NULL
with	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:2526-2535	NULL
.	NULL

28	NULL
.	NULL

Erzurum	NULL
,	NULL
S.C.	NULL
,	NULL
G.P	NULL
.	NULL

Downey	NULL
,	NULL
D.E	NULL
.	NULL

Doherty	NULL
,	NULL
B.	NULL
Schwab	NULL
,	NULL
III	NULL
,	NULL
E.L.	NULL
Elson	NULL
,	NULL
and	NULL
G.S	NULL
.	NULL

Worthen	NULL
.	NULL

1992	NULL
.	NULL

Mechanisms	NULL
of	NULL
lipopolysaccharide-induced	NULL
neutrophil	NULL
retention	NULL
:	NULL
relative	NULL
contributions	NULL
of	NULL
adhesive	NULL
and	NULL
cellular-mechanical	NULL
properties	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:154-162	NULL
.	NULL

29	NULL
.	NULL

Guthrie	NULL
,	NULL
L.A.	NULL
,	NULL
L.C	NULL
.	NULL

McPhail	NULL
,	NULL
P.M.	NULL
Henson	NULL
,	NULL
and	NULL
R.B	NULL
.	NULL

Johnston	NULL
,	NULL
Jr.	NULL
1984	NULL
.	NULL

Priming	NULL
of	NULL
neutrophils	NULL
for	NULL
enhanced	NULL
release	NULL
of	NULL
oxygen	NULL
metabolites	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
:	NULL
evidence	NULL
for	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
superoxide-producing	NULL
enzyme	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160:1656-1671	NULL
.	NULL

30	NULL
.	NULL

Hiester	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
and	NULL
P.	NULL
Campbell	NULL
.	NULL

1992	NULL
.	NULL

Interleukin-4	NULL
is	NULL
chemotactic	NULL
for	NULL
mouse	NULL
macrophages	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

139:72-80	NULL
.	NULL

31	NULL
.	NULL

Grynkiewicz	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Poenie	NULL
,	NULL
and	NULL
R.	NULL
Tsien	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
new	NULL
generation	NULL
of	NULL
calcium	NULL
indicators	NULL
with	NULL
greatly	NULL
improved	NULL
fluorescence	NULL
properties	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260:3440-3450	NULL
.	NULL

32	NULL
.	NULL

Haslett	NULL
,	NULL
C.	NULL
,	NULL
L.A.	NULL
Guthrie	NULL
,	NULL
M.M	NULL
.	NULL

Kopaniak	NULL
,	NULL
R.B	NULL
.	NULL

Johnston	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
P.M.	NULL
Henson	NULL
.	NULL

1985	NULL
.	NULL

Modulation	NULL
of	NULL
multiple	NULL
neutrophil	NULL
functions	NULL
by	NULL
preparative	NULL
methods	NULL
or	NULL
trace	NULL
concentrations	NULL
of	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

119:101-110	NULL
.	NULL

33	NULL
.	NULL

Buhl	NULL
,	NULL
A.M.	NULL
,	NULL
N.	NULL
Avdi	NULL
,	NULL
G.S	NULL
.	NULL

Worthen	NULL
,	NULL
and	NULL
G.L	NULL
.	NULL

Johnson	NULL
.	NULL

1994	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
CSa	NULL
receptor	NULL
signal	NULL
transduction	NULL
network	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:9190-9194	NULL
.	NULL

34	NULL
.	NULL

Griswold	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
P.J	NULL
.	NULL

Marshall	NULL
,	NULL
E.F.	NULL
Webb	NULL
,	NULL
R.	NULL
Godfrey	NULL
,	NULL
J.	NULL
Newton	NULL
,	NULL
Jr.	NULL
,	NULL
M.J.	NULL
DiMartino	NULL
,	NULL
H.M.	NULL
Sarau	NULL
,	NULL
J.G	NULL
.	NULL

Gleason	NULL
,	NULL
G.	NULL
Poste	NULL
,	NULL
and	NULL
N.	NULL
Hanna	NULL
.	NULL

1987	NULL
.	NULL

SK	NULL
&	NULL
F	NULL
86002	NULL
:	NULL
A	NULL
structurally	NULL
novel	NULL
anti-inflammatory	NULL
agent	NULL
that	NULL
inhibits	NULL
lipoxy-genase-	NULL
and	NULL
cyclooxygenase-mediated	NULL
metabolism	NULL
of	NULL
arachidonic	NULL
acid	NULL
.	NULL

Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

36:3463-3470	NULL
.	NULL

35	NULL
.	NULL

Lee	NULL
,	NULL
J.C.	NULL
,	NULL
J.T	NULL
.	NULL

Laydon	NULL
,	NULL
P.C	NULL
.	NULL

McDonnell	NULL
,	NULL
T.F	NULL
.	NULL

Gallagher	NULL
,	NULL
S.	NULL
Kumar	NULL
,	NULL
D.	NULL
Green	NULL
,	NULL
D.	NULL
McNulty	NULL
,	NULL
M.J.	NULL
Blumenthal	NULL
,	NULL
J.R.	NULL
Heys	NULL
,	NULL
S.W	NULL
.	NULL

Landvatter	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosyn-	NULL
Platelet	NULL
Activating	NULL
Factor	NULL
and	NULL
FMLP	NULL
Induced	NULL
Intracellular	NULL
Signaling	NULL
in	NULL
Neutrophils	NULL
985	NULL
thesis	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

372:739-746	NULL
.	NULL

36	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

Rouse	NULL
,	NULL
Y.N	NULL
.	NULL

Doza	NULL
,	NULL
R.	NULL
Meier	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
T.F	NULL
.	NULL

Gallagher	NULL
,	NULL
P.R	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
J.C.	NULL
Lee	NULL
.	NULL

1995	NULL
.	NULL

SB	NULL
203580	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
a	NULL
MAP	NULL
kinase	NULL
homologue	NULL
which	NULL
is	NULL
stimulated	NULL
by	NULL
cellular	NULL
stresses	NULL
and	NULL
interleukin-1	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

64:229-233	NULL
.	NULL

37	NULL
.	NULL

Morel	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Doussiere	NULL
,	NULL
and	NULL
P.V	NULL
.	NULL

Vignais	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
superoxide-generat-ing	NULL
oxidase	NULL
of	NULL
phagocytic	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

201:523-546	NULL
.	NULL

38	NULL
.	NULL

Bokoch	NULL
,	NULL
G.M	NULL
.	NULL

1995	NULL
.	NULL

Chemoattractant	NULL
signaling	NULL
and	NULL
leukocyte	NULL
activation	NULL
.	NULL

Blood	NULL
.	NULL

86:1649-1660	NULL
.	NULL

39	NULL
.	NULL

Nemenoff	NULL
,	NULL
R.A.	NULL
,	NULL
S.	NULL
Winitz	NULL
,	NULL
N.-X	NULL
.	NULL

Qian	NULL
,	NULL
V.	NULL
Van	NULL
Putten	NULL
,	NULL
G.L	NULL
.	NULL

Johnson	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Heasley	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
a	NULL
high	NULL
molecular	NULL
weight	NULL
form	NULL
of	NULL
phospholipase	NULL
A	NULL
;	NULL
by	NULL
p42	NULL
microtubule-associated	NULL
protein	NULL
2	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:1960-1964	NULL
.	NULL

40	NULL
.	NULL

Lin	NULL
,	NULL
L.-L.	NULL
,	NULL
M.	NULL
Wartmann	NULL
,	NULL
A.	NULL
Y.	NULL
Lin	NULL
,	NULL
J.L	NULL
.	NULL

Knopf	NULL
,	NULL
A.	NULL
Seth	NULL
,	NULL
and	NULL
R.J.	NULL
Davis	NULL
.	NULL

1993.	NULL
cPLA	NULL
,	NULL
is	NULL
phosphorylated	NULL
and	NULL
activated	NULL
by	NULL
MAP	NULL
kinase	NULL
.	NULL

Cell	NULL
.	NULL

72:269-278	NULL
.	NULL

41	NULL
.	NULL

Ben-Levy	NULL
,	NULL
R.	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Leighton	NULL
,	NULL
Y.N	NULL
.	NULL

Doza	NULL
,	NULL
P.	NULL
Attwood	NULL
,	NULL
N.	NULL
Morrice	NULL
,	NULL
C.J	NULL
.	NULL

Marshall	NULL
,	NULL
and	NULL
P.	NULL
Cohen	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
novel	NULL
phosphorylation	NULL
sites	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
MAPKAP	NULL
kinase-2	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
)	NULL
J	NULL
.	NULL

14:5920-5930	NULL
.	NULL

42	NULL
.	NULL

McLaughlin	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
S.	NULL
Kumar	NULL
,	NULL
P.C	NULL
.	NULL

McDonnell	NULL
,	NULL
S.	NULL
Van	NULL
Horn	NULL
,	NULL
J.C.	NULL
Lee	NULL
,	NULL
G.P	NULL
.	NULL

Livi	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Young	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase-activated	NULL
protein	NULL
kinase-3	NULL
,	NULL
a	NULL
novel	NULL
substrate	NULL
of	NULL
CSBP	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8488-8492	NULL
.	NULL

43	NULL
.	NULL

Amatruda	NULL
,	NULL
TT	NULL
.	NULL

,	NULL
N.P	NULL
.	NULL

Gerard	NULL
,	NULL
C.	NULL
Gerard	NULL
,	NULL
and	NULL
M.I	NULL
.	NULL

Simon	NULL
.	NULL

1993	NULL
.	NULL

Specific	NULL
interactions	NULL
of	NULL
chemoattractant	NULL
factor	NULL
receptors	NULL
with	NULL
G-proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:10139-10144	NULL
.	NULL

44	NULL
.	NULL

Honda	NULL
,	NULL
Z.	NULL
,	NULL
T.	NULL
Takano	NULL
,	NULL
Y.	NULL
Gotoh	NULL
,	NULL
E.	NULL
Nishida	NULL
,	NULL
K.	NULL
Itoh	NULL
,	NULL
and	NULL
T.	NULL
Shimizu	NULL
.	NULL

1994	NULL
.	NULL

Transfected	NULL
platelet-activating	NULL
factor	NULL
receptor	NULL
activates	NULL
mitogen-activated	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
and	NULL
MAP	NULL
kinase	NULL
kinase	NULL
in	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:2307-2315	NULL
.	NULL

45	NULL
.	NULL

Lad	NULL
,	NULL
P.M.	NULL
,	NULL
C.V.	NULL
Olson	NULL
,	NULL
and	NULL
I.S	NULL
.	NULL

Grewal	NULL
.	NULL

1985	NULL
.	NULL

Platelet-activating	NULL
factor	NULL
mediated	NULL
effects	NULL
on	NULL
human	NULL
neutrophil	NULL
function	NULL
are	NULL
inhibited	NULL
by	NULL
pertussis	NULL
toxin	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

129:632-638	NULL
.	NULL

986	NULL
-	NULL
Nick	NULL
et	NULL
al	NULL
.	NULL

46	NULL
.	NULL

Lad	NULL
,	NULL
P.M.	NULL
,	NULL
C.V.	NULL
Olson	NULL
,	NULL
IS	NULL
.	NULL

Grewal	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Scott	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
pertussis	NULL
toxin-sensitive	NULL
GTP-binding	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
neutrophil	NULL
regulates	NULL
multiple	NULL
receptors	NULL
,	NULL
calcium	NULL
mobilization	NULL
,	NULL
and	NULL
lectin-induced	NULL
capping	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

82:8643-8647	NULL
.	NULL

47	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
L-H.	NULL
Wu	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
R.J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Independent	NULL
human	NULL
MAP	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
defined	NULL
by	NULL
MEK	NULL
and	NULL
MKK	NULL
isoforms	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

267:682-685	NULL
.	NULL

48	NULL
.	NULL

Lin	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Minden	NULL
,	NULL
H.	NULL
Martinetto	NULL
,	NULL
F.-X	NULL
.	NULL

Claret	NULL
,	NULL
C.	NULL
Lange-Carter	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
G.L	NULL
.	NULL

Johnson	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
dual-specificity	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
Jun	NULL
kinases	NULL
and	NULL
p38-Mpk2	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

268	NULL
:	NULL
286-290	NULL
.	NULL

49	NULL
.	NULL

Cockcroft	NULL
,	NULL
S.	NULL
1992	NULL
.	NULL

G-protein-regulated	NULL
phospholipase	NULL
C	NULL
,	NULL
D	NULL
and	NULL
A2Z-mediated	NULL
signalling	NULL
in	NULL
neutrophils	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1113:135-160	NULL
.	NULL

50	NULL
.	NULL

Mullmann	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Cheewatrakoolpong	NULL
,	NULL
J.	NULL
Anthes	NULL
,	NULL
M.	NULL
Siegel	NULL
,	NULL
R.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
Billah	NULL
.	NULL

1993	NULL
.	NULL

Phospholipase	NULL
C	NULL
and	NULL
phospholipase	NULL
D	NULL
are	NULL
activated	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
in	NULL
chemotactic	NULL
peptide-stimulated	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Leuk	NULL
.	NULL

Biol	NULL
.	NULL

53:630-635	NULL
.	NULL

51	NULL
.	NULL

Billah	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Eckel	NULL
,	NULL
T.	NULL
Mullmann	NULL
,	NULL
R.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
Siegel	NULL
.	NULL

1989	NULL
.	NULL

Phos-phatidylcholine	NULL
hydrolysis	NULL
by	NULL
phospholipase	NULL
D	NULL
determines	NULL
phosphatidate	NULL
and	NULL
diglyceride	NULL
levels	NULL
in	NULL
chemotactic	NULL
peptide-stimulated	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:17069-17077	NULL
.	NULL

52	NULL
.	NULL

Bradford	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Rubin	NULL
.	NULL

1986	NULL
.	NULL

Quantitative	NULL
changes	NULL
in	NULL
inositol	NULL
1,4,5-triphosphate	NULL
in	NULL
chemoattractant-stimulated	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261	NULL
:	NULL
15644-15647	NULL
.	NULL

53	NULL
.	NULL

Tauber	NULL
,	NULL
A	NULL
.	NULL

1987	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
neutrophil	NULL
NADPH-oxidase	NULL
.	NULL

Blood	NULL
.	NULL

69:711-720	NULL
.	NULL

54	NULL
.	NULL

Dang	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Hakim	NULL
,	NULL
and	NULL
A.	NULL
Perianin	NULL
.	NULL

1994	NULL
.	NULL

Immunochemical	NULL
identification	NULL
and	NULL
translocation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
zeta	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

349:388-342	NULL
.	NULL

55	NULL
.	NULL

Kramer	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
E.F.	NULL
Roberts	NULL
,	NULL
B.A	NULL
.	NULL

Strifler	NULL
,	NULL
and	NULL
E.M.	NULL
Johnstone	NULL
.	NULL

1995	NULL
.	NULL

Thrombin	NULL
induces	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
human	NULL
platelets	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27395-27398	NULL
.	NULL

